In this solo episode of The Energy Code, Dr. Mike Belkowski breaks down some of the most interesting research to emerge over the past two weeks across optogenetics, mitochondrial aging, methylene blue, oral photobiomodulation, urolithin A and B, mitochondrial peptides, GLP-1 drugs, molecular hydrogen, and circadian biology.

The episode begins with the 2026 Nobel Prize in Physiology or Medicine and the revolutionary idea behind optogenetics: light can be used to control biological activity with extraordinary precision. Importantly, optogenetics is not red light therapy — but the recognition reinforces a much broader principle: photons can function as biological signals.

From there, Mike explores new evidence implicating the mitochondrial membrane lipid cardiolipin in age-related muscle changes, a fascinating new study showing that methylene blue alters electron transport in a highly concentration-dependent manner, and the growing clinical literature around photobiomodulation for oral health.

The episode also examines emerging differences between urolithin A and urolithin B, new research on the cardiolipin-targeting mitochondrial peptide SS-31, phase 3 data on retatrutide, the next generation of multi-hormone metabolic drugs, new approaches to delivering molecular hydrogen, and evidence that light exposure and circadian timing can alter metabolism far beyond sleep.

The common thread? Biology isn't merely chemistry. It's electrochemistry, photons, electrons, membrane potentials, redox signals, molecular information — and time.

And that may require us to rethink what “mitochondrial health” actually means.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

“One of the highest honors in all of science just went to researchers whose work demonstrated that light can be used to control biology with extraordinary precision.”

“The takeaway is that methylene blue can redistribute mitochondrial electron flow.”

“Urolithin A and urolithin B should be studied as distinct biological molecules rather than interchangeable urolithins.”

“The pharmaceutical industry is essentially reverse engineering the network of hormonal signals that collectively tell the brain and body, ‘We've eaten, energy is available.’”

“Circadian biology isn't about performing one perfect morning light session. It's about creating a repeated light-dark pattern that the brain can learn.”

(In regards to the goal of improving mitochondrial function = improving ATP production: "Maybe the deeper goal is restoring the mitochondria's ability to respond appropriately to information.”

-

Key Points

⚡ Light wins the Nobel: The 2026 Nobel Prize in Physiology or Medicine recognizes discoveries underlying optogenetics and the ability to control cellular activity using light.

⚡ Optogenetics ≠ red light therapy: The mechanisms are fundamentally different, but both underscore the biological importance of photons.

⚡ Cardiolipin emerges as an aging target: New research suggests declining cardiolipin synthesis may contribute causally to age-related changes in skeletal muscle.

⚡ Mitochondria aren't identical batteries: Their structure, location, membrane architecture, respiratory behavior, and redox state can all influence function.

⚡ Methylene blue gets more complicated: New mechanistic research shows it can redistribute electron flow across the respiratory chain, with effects heavily dependent on concentration and mitochondrial state.

⚡ Oral photobiomodulation evidence continues growing: Larger meta-analyses suggest potential benefits across burning mouth syndrome, implant recovery, pain, and other oral applications—but inconsistent dosimetry remains a major limitation.

⚡ Urolithin A and B aren't interchangeable: New research in human muscle cells revealed strikingly different gene-expression signatures between the two metabolites.

⚡ SS-31 converges on cardiolipin: New research adds to the case for targeting mitochondrial membrane integrity rather than simply trying to increase ATP.

⚡ Retatrutide delivers major Phase 3 results: The GLP-1/GIP/glucagon triple agonist produced approximately 25% mean weight loss at the highest study dose.

⚡ The next generation of metabolic drugs is already emerging: Researchers are moving beyond individual GLP-1 pathways toward combinations targeting multiple metabolic signals simultaneously.

⚡ Hydrogen's future may be about delivery: New technology is exploring ways to control where, when, and for how long molecular hydrogen is released.

⚡ Circadian timing changes metabolism: Night-shift research demonstrates that eating less doesn't necessarily produce better glucose control when food is consumed at a biologically inappropriate time.

⚡ Your circadian system may have a “temporal memory”: Light exposure today may influence how your biological clock responds tomorrow.

⚡ Mitochondrial health is about more than ATP: The deeper goal may be restoring mitochondria's ability to appropriately sense, respond to, and communicate biological information.

⚡ The bigger picture: Photons, electrons, redox signals, membrane potentials, molecular signals, and time are increasingly converging within our understanding of human biology.

-

Episode timeline

00:00 — Welcome to The Energy Code & What's Ahead 01:21 — BioLight Mito Prime Day 03:20 — Light Just Won the Nobel Prize 05:44 — Why Optogenetics Is Such a Big Deal 07:18 — Optogenetics vs. Red Light Therapy 08:37 — Photons as Biological Control Signals 09:49 — Mitochondria Are Much More Than ATP Factories 10:43 — Cardiolipin: An Overlooked Key to Mitochondrial Aging 12:05 — What Happens When Cardiolipin Declines? 13:12 — Why Mitochondrial Membrane Architecture Matters 14:25 — Not All Mitochondria Are Created Equal 15:32 — New Methylene Blue Research 17:47 — Methylene Blue, ROS & the Biphasic Response 19:08 — Methylene Blue as an Electron-Flow Modulator 20:05 — The Growing Evidence for Oral Photobiomodulation 20:29 — Red Light Therapy for Burning Mouth Syndrome 22:47 — Why PBM Dosimetry Matters 24:35 — Red Light Therapy Around Dental Implants 26:23 — Intraoral vs. Extraoral Photobiomodulation 28:02 — Urolithin A vs. Urolithin B 29:15 — New Human Muscle-Cell Research 30:21 — The Different Pathways Activated by Urolithin A & B 32:30 — Urolithin B, Mitophagy & Why It's One to Watch 33:22 — SS-31 Meets Cardiolipin 34:33 — Mitochondrial Peptides & the Longevity Conversation 36:14 — Why Mechanistic Peptide Research ≠ Human Dosing Protocols 36:44 — Retatrutide's Major Phase 3 Results 38:20 — What Comes After Retatrutide? 40:24 — The Rise of Multi-Hormone Metabolic Drugs 40:54 — What Do GLP-1 Drugs Actually Do to Mitochondria? 42:23 — A New Approach to Molecular Hydrogen 44:24 — Why Delivery May Matter as Much as the Molecule 44:50 — Circadian Biology Is About Much More Than Sleep 45:20 — Night Shifts, Meal Timing & Glucose Control 46:08 — Nighttime Light, the Liver & Metabolism 47:22 — How Light Signals Reach the Rest of the Body 48:01 — The Brain's Master Circadian Clock 48:52 — Your Circadian System Has a “Temporal Memory” 49:29 — Connecting All the New Research 51:32 — Photons, Electrons, Protons, Membrane Potentials & Time 52:04 — A New Definition of Mitochondrial Health 53:34 — Final Takeaway: Mitochondrial Medicine Is Now

-

→ Explore the MitoPrime Day Sale!

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this episode of The Energy Code, Dr. Mike Belkowski sits down with Harry Massey, pioneer in bioenergetics and founder of NES Health and Energy for Life, for a deep dive into the relationship between energy, information, biology, and the human body.

Harry shares the story behind his own decades-long health journey, beginning with multiple accidents and years of severe illness that ultimately led him to explore bioenergetics, quantum biology, mitochondrial function, light, electromagnetism, and the body’s biological energy field.

The conversation explores Harry’s work with Professor Peter Fraser and the idea that the body may have multiple control systems beyond conventional chemical signaling. They discuss the concept of the biofield, how information may influence cellular function, and the development of technologies designed to deliver information through light, electromagnetic signals, and structured water.

Mike and Harry also dive deep into mitochondrial energy and the idea that the body functions as a giant energy exchange system. They discuss photons, electrons, ATP, structured water, the mitochondria, and why Harry believes improving the body’s ability to acquire, store, and efficiently use energy is fundamental to health.

The discussion then moves into EMF, grounding, emotional stress, trauma, and the potential impact of mindset on health. Harry explains why he no longer views EMF as something to fear in every circumstance and why he believes dose, duration, and the body’s overall state matter when thinking about environmental exposures.

They also explore the controversial concept of water memory, the role of structured water inside cells, hydrogen, emerging bioenergetic technologies, and Harry’s vision for combining wearable technology, AI, biological data, and energy-based interventions.

Harry also reveals his “vitality equation” — information × energy ÷ resistance — and explains why he considers the body’s “battery” one of the most underrated factors in human health.

The episode closes with a rapid-fire discussion covering morning sunlight, red light therapy, grounding, structured water, emotional stress, peptides, lifestyle fundamentals, and what Harry believes we may understand about the human body 20 years from now.

(Educational content only, not medical advice.)

_

Key Quotes From Harry:

_

Key Points

⚡ Harry Massey’s journey into bioenergetics began after years of severe health problems following multiple accidents and illness, ultimately leading him to spend decades studying energy, information, and biology.

⚡ Harry describes the body as having multiple control systems, including conventional chemical signaling, the nervous system, and what he calls the body’s energy or biofield.

⚡ The conversation explores the idea that information carried through fields may influence cellular function and biological processes.

⚡ Harry discusses his work with Professor Peter Fraser and the development of technologies based on what they viewed as informational patterns within the body.

⚡ Light, electromagnetic signals, and structured water are discussed as potential ways of delivering information to biological systems.

⚡ Harry explains his view that mitochondria are one component of a much larger energy system operating throughout the body.

⚡ The conversation examines photons, electrons, ATP, the Krebs cycle, and the role of electron flow in biological energy production.

⚡ Harry introduces the concept of the “body battery,” arguing that health depends in part on balancing the energy entering the body with the energy being consumed.

⚡ Three major principles emerge from Harry’s approach: increase energy exchange with the environment, manage energy demands, and improve the efficiency with which the body uses energy.

⚡ Walking, sunlight, red light, rest, methylene blue, and other modalities are discussed in the context of energy exchange and energy efficiency.

⚡ The discussion challenges the idea that grounding is universally necessary, with Harry explaining why he personally considers it less important than some other sources of environmental energy.

⚡ EMF is examined through the concept of dose and duration rather than as an all-or-nothing exposure.

⚡ Harry explains why he believes fear and chronic emotional stress may have a greater impact on health than many of the environmental exposures people worry about.

⚡ The conversation explores the relationship between emotional trauma, the body’s control systems, and the biofield.

⚡ Mike and Harry discuss experiences with biofield-oriented practices including bodywork, hypnotherapy, tuning forks, and other approaches intended to influence the body’s energetic state.

⚡ Structured water becomes a major part of the conversation, including Harry’s explanation of how he believes water interacts with infrared energy and electron production.

⚡ Harry discusses the controversial concept of “water memory” and its potential relationship to biological information and cellular function.

⚡ The conversation explores how water inside cells may interact with DNA, RNA, proteins, energy, and informational signals.

⚡ Hydrogen and hydrogen water are discussed as emerging areas of interest within Harry’s ongoing research and product development.

⚡ Harry shares his vision for combining wearable technology, AI, pulse data, facial and tongue analysis, voice biomarkers, and bioenergetic interventions into a personalized health platform.

⚡ Harry discusses a forthcoming app and wearable technology designed around this approach to health optimization.

⚡ Harry also discusses Beyond Medicine, a documentary exploring his personal journey, inventions, and the science behind his work.

⚡ In the rapid-fire segment, Harry identifies emotional stress as the biggest energy drain in modern life and the body’s “battery” as one of the most underrated factors in human energy.

⚡ Harry’s “vitality equation” is information × energy ÷ resistance.

⚡ Harry argues that lifestyle fundamentals should come before an endless pursuit of increasingly complex biohacking interventions.

⚡ The conversation ultimately returns to a central idea: understanding human health may require looking beyond chemistry and examining how energy and information interact with biology.

_

Episode Timeline

00:00 — Introducing Harry Massey & Bioenergetics

01:54 — The Accidents & Illness That Started Harry’s Journey

04:32 — Why Harry Started Studying Bioenergetics

05:18 — Meeting Professor Peter Fraser

07:24 — The Body’s Multiple Control Systems

08:25 — Information, Light & Electromagnetic Signals

10:02 — The Biofield & Informational Remedies

12:05 — Mitochondrial Efficiency & Cellular Energy

15:53 — Electrical Signals & Tissue Repair

17:16 — Reading the Body Through Face, Tongue, Pulse & Voice

18:53 — AI Health Coaching & Wearable Technology

20:29 — Why Harry Started Studying Mitochondria

21:13 — Photons, Electrons & The Energy Exchange System

24:04 — The Body Battery Concept

26:30 — Three Principles for Optimizing Energy

27:41 — Grounding: Helpful or Overhyped?

31:24 — EMF, Dose & The Bioenergetic Response

38:24 — Trauma, Emotional Stress & Health

39:59 — Harry’s Gratitude, Intention, Surrender & Trust Practice

42:45 — The Biofield, Hypnotherapy & Body Talk

45:23 — Emotional Trauma & The Body’s Control System

49:02 — Water Quality & Structured Water

51:11 — The Controversy Around Water Memory

54:13 — Structured Water, DNA & Cellular Repair

57:00 — Water, Emotion & Biological Information

59:00 — Hydrogen & Emerging Bioenergetic Technologies

1:02:20 — The Future of Healing Technology

1:03:29 — Beyond Medicine Documentary

1:04:40 — Rapid-Fire Bioenergetics Questions

1:05:10 — The Body Battery & Vitality Equation

1:05:48 — Are Peptides Overhyped?

1:09:29 — Can the Body Heal Without Restoring Cellular Energy?

1:10:16 — What Will We Understand About the Human Body in 20 Years?

1:10:42 — Measuring the Human Biofield

1:11:11 — “Human Health Begins With Energy”

_

Follow Harry on Instagram → @HarryMasseyOfficial

Learn more about Harry → HarryMassey.com

Energy for Life → E4L.com

Beyond Medicine Documentary → BeyondMedicine.movie

-

BioLight Labs

Research Use Only Peptides

Both injectables & nasal spray solutions

High purity. High sterility. Low endotoxin. Verified through rigorous quality testing.

Explore Peptides → BioLight Labs

_

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this episode of The Energy Code, Dr. Mike Belkowski and Don Bailey explore one of the most overlooked concepts in peptide science: mitochondrial health may determine how well your body responds to peptide signaling.

The conversation dives into why healthy mitochondria provide the energy required for peptide signaling, how inflammation and oxidative stress can reduce peptide sensitivity, and why optimizing cellular energy may improve the effectiveness of both your body's own peptides and therapeutic peptides like Retatrutide, BPC-157, GLP-1s, and more.

They also discuss Don's personal Retatrutide journey, microdosing strategies, preserving muscle during weight loss, insulin resistance, GLP-1 biology, HRV changes, receptor signaling, ATP production, oxidative stress, and why improving mitochondrial function could become one of the most important ways to maximize peptide outcomes.

If you're interested in peptides, longevity, metabolism, or mitochondrial health, this episode connects these topics in a way you've probably never heard before.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

"Mitochondrial dysfunction may be one of the biggest reasons people respond differently to peptides."

"The better your mitochondria function, the better your body can respond to both endogenous and therapeutic peptides."

"A peptide can bind perfectly to its receptor and still fail if the cell doesn't have the energy to respond."

"The downstream response to a peptide is incredibly energy intensive."

(In regards to weight loss): "Lose the inflammation, improve the mitochondria, improve peptide sensitivity."

"The goal isn't the highest peptide dose. It's the greatest response from the lowest effective dose."

"Retatrutide should be viewed as a long-term metabolic tool — not a race to lose weight."

"Improving mitochondria may be one of the most overlooked ways to maximize peptide therapy."

-

Key Points

⚡ Mitochondrial health may be one of the biggest factors determining how effectively your body responds to peptides.

⚡ Peptides don't work in isolation—they require healthy, energy-producing cells to generate their full biological response.

⚡ ATP produced by mitochondria powers the downstream signaling that allows peptides to carry out their functions.

⚡ Mitochondrial dysfunction may reduce peptide sensitivity, even when receptors and peptide levels are normal.

⚡ Inflammation and oxidative stress can create "cellular noise" that interferes with peptide signaling pathways.

⚡ Insulin resistance is a real-world example of peptide resistance, demonstrating how poor metabolic health can impair cellular communication.

⚡ Improving mitochondrial function may enhance both your body's naturally produced peptides and therapeutic peptides.

⚡ Losing excess body fat can improve mitochondrial function, reduce inflammation, and restore healthier peptide signaling.

⚡ GLP-1 medications like Retatrutide may work even better when combined with strategies that optimize mitochondrial health.

⚡ Microdosing peptides may produce excellent results when cellular bioenergetics are optimized, reducing the need for higher doses.

⚡ Peptide signaling requires far more than receptor binding—it depends on energy-intensive intracellular processes driven by healthy mitochondria.

⚡ Healthy mitochondria help cells respond more efficiently to repair, growth, metabolic, and anti-inflammatory peptide signals.

⚡ The discussion highlights why two people taking the same peptide can experience dramatically different outcomes.

⚡ Optimizing mitochondrial function through nutrition, exercise, red light therapy, sleep, and metabolic health may improve peptide responsiveness.

⚡ The future of peptide medicine may involve treating mitochondrial dysfunction first to maximize the effectiveness of peptide therapies.

-

Episode timeline

00:00 — Welcome Back & Don's Retatrutide Experience

03:00 — Losing Weight Without Losing Muscle

06:15 — Why Fat Creates Mitochondrial Dysfunction

08:20 — Why Your Body Needs More Than Natural GLP-1

11:20 — GLP-1s Beyond Weight Loss

13:00 — Retatrutide Side Effects & Real-World Experience

17:00 — Why We Microdose Retatrutide

20:45 — GLP-1 vs Tirzepatide vs Retatrutide

22:00 — HRV, Heart Rate & Retatrutide

25:00 — What Is Peptide Sensitivity?

28:30 — ATP: The Missing Piece of Peptide Signaling

30:30 — Mitochondrial Dysfunction Creates Peptide Resistance

33:00 — Oxidative Stress, Redox & Cellular Noise

35:30 — What Sparked This Entire Conversation

37:45 — Receptor Trafficking & Why Mitochondria Matter

-

BioLight Labs

Research Use Only Peptides

Both injectables & nasal spray solutions

High purity. High sterility. Low endotoxin. Verified through rigorous quality testing.

Explore Peptides → BioLight Labs

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this episode, Dr. Mike Belkowski breaks down the most important developments shaping the future of peptide science, longevity, metabolism, and mitochondrial medicine.

From major FDA regulatory changes and groundbreaking clinical trials to the next generation of GLP-1 drugs, mitochondrial peptides, amylin agonists, oral peptide therapeutics, and the latest pharmaceutical breakthroughs, this episode explores where peptide medicine is headed over the next several years.

You'll also hear why MOTS-c may be transitioning from a "biohacker peptide" into legitimate clinical medicine, why SS-31 represents a milestone for mitochondrial therapeutics, why retatrutide continues to redefine metabolic medicine, and which peptide trends deserve your attention moving forward.

If you're interested in longevity, mitochondrial health, bioenergetics, metabolic optimization, or simply want to stay ahead of one of the fastest-moving fields in medicine, this episode is your comprehensive update.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

"The committee wasn't voting on whether these peptides work. They were voting on whether licensed compounding pharmacies should be allowed to prepare them."

"Retatrutide is rapidly evolving from a weight-loss drug into a multi-system metabolic therapeutic."

"Mitochondrial-targeted peptide therapy is becoming a legitimate therapeutic category."

"MOTS-c is becoming one of the first true biohacker peptides to enter legitimate pharmaceutical research."

"SS-31 is no longer theoretical — mitochondrial peptide therapy is now a clinical reality."

"Intranasal mitochondrial peptides may have enormous future potential for brain health."

"Amylin may become wave three of metabolic medicine."

"Developers are now targeting energy expenditure, liver metabolism, adipose biology, and insulin signaling simultaneously."

"Oral peptide therapeutics may become one of the biggest pharmaceutical revolutions of the next decade."

"Peptides are one of the most exciting frontiers in health, longevity, and human energy."

-

Key Points

⚡ 2026 is becoming a landmark year for peptide science, regulation, and clinical development.

⚡ Four new BioLight Labs intranasal peptides were announced: MOTS-c, MOTS-c + SS-31, Oxytocin, and BPC-157.

⚡ The FDA's Pharmacy Compounding Advisory Committee recommended six peptides for potential future 503A compounding inclusion while rejecting DSIP.

⚡ Those FDA recommendations are advisory—not approvals—and formal rulemaking is still required.

⚡ Retatrutide continues to produce unprecedented weight-loss results approaching bariatric surgery outcomes.

⚡ GLP-1 therapies are evolving beyond weight loss into treatments for metabolic disease, sleep apnea, osteoarthritis, and other chronic conditions.

⚡ Amylin peptides are emerging as the next major frontier in obesity and metabolic medicine.

⚡ Petrelintide demonstrated impressive weight loss with placebo-like gastrointestinal tolerability.

⚡ Novo Nordisk's dual GLP-1/amylin peptide is advancing rapidly through clinical development.

⚡ MOTS-c has entered a randomized Phase 2 clinical trial, representing a major milestone for mitochondrial peptides.

⚡ MOTS-c is becoming one of the first "biohacker peptides" to transition into rigorous pharmaceutical research.

⚡ SS-31 (Elamipretide) became an FDA-approved mitochondrial-targeted peptide therapy for Barth syndrome.

⚡ Mitochondrial peptides are rapidly evolving from experimental longevity compounds into legitimate therapeutic candidates.

⚡ Dr. David Perlmutter's new book highlights mitochondrial health as a critical determinant of microglial function and brain health.

⚡ Intranasal mitochondrial peptides may eventually become promising tools for brain injury, stroke recovery, and neurodegeneration.

⚡ Servodutide is showing remarkable promise for fatty liver disease and obesity.

⚡ Pemvidutide produced encouraging Phase 2 results for alcohol use disorder.

⚡ Oral macrocyclic peptides are transforming peptide drug development by eliminating the need for injections.

⚡ Regulatory momentum around peptides continues to accelerate faster than human clinical evidence.

⚡ The peptide field is splitting into two worlds: highly engineered pharmaceutical drugs and early-stage regenerative peptides.

⚡ Curiosity should always be balanced with scientific evidence, safety, and quality.

-

Episode timeline

00:00 — Introduction & New BioLight Labs Intranasal Peptides

04:14 — FDA Peptide Regulatory Update

07:01 — Retatrutide Continues to Impress

08:44 — Amylin: The Next Metabolic Frontier

11:39 — MOTS-c Enters Phase 2 Clinical Trials

12:55 — Humanin, SHLPs & SS-31

14:47 — Brain Health, Microglia & Dr. David Perlmutter

18:48 — Servodutide & Fatty Liver Disease

19:55 — Pemvidutide & Addiction Research

21:35 — The Rise of Oral Peptides

22:57 — BPC-157, TB-500 & KPV: Regulatory Momentum vs Clinical Evidence

24:16 — FDA Preparing for the Generic GLP-1 Era

25:47 — Eight Peptide Trends to Watch

30:38 — Final Takeaways & The Future of Peptide Medicine

-

BioLight Labs

Research Use Only Peptides

Both injectables & nasal spray solutions

High purity. High sterility. Low endotoxin. Verified through rigorous quality testing.

Explore Peptides → BioLight Labs

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Jarrod shares his deeply personal journey into frequency medicine, including how a severe spinal injury and emergency surgery led him to discover The Light System and the technology he credits with dramatically accelerating his recovery.

Together, they explore the history and concepts behind The Light System, a technology originally developed by inventor Robert J. that uses coded affirmations, sacred geometry, and polychromatic light frequencies. Jarrod explains the system’s theories around cellular water, electrical voltage, energy flow, and the body’s ability to recover and adapt.

The conversation covers everything from bio-photonic collisions and water restructuring to EMF-mitigating technology, quantum-charged vessels, cellular voltage, mindset, and the potential relationship between energy flow and human resilience.

Educational content only. This episode is not medical advice.

• Jarrod Barakett’s journey into frequency medicine and his recovery from a severe spinal injury • The history and origins of The Light System • Sacred geometry and its role in frequency-based technologies • How water may interact with frequency, words, and intention • Polychromatic light and bio-photonic collisions • Cellular electrical charge and the concept of “cellular voltage” • Environmental stressors including Bluetooth, Wi-Fi, and processed foods • Buccal cell testing and measurements of electrical conductivity • Quantum-charged water bottles, jewelry, and other products • The Light System’s approach to EMF exposure • Mental clarity, emotional resilience, grief, and energy flow • The placebo effect and the connection between mindset and physiology • Sunlight, frequency, peptides, and the future of medicine

• Jarrod’s personal recovery experience was a major catalyst for his interest in frequency medicine.

• The Light System was developed around the concept of delivering coded affirmations through specific light frequencies.

• The technology incorporates concepts including sacred geometry, polychromatic light, and frequency-based interactions with water.

• Jarrod discusses the theory that restructuring cellular water may influence energy flow throughout the body.

• Hybrid Light System units use opposing monitors to create what Jarrod describes as bio-photonic collisions and an associated energy field.

• The conversation explores the idea that modern environmental factors may affect the body’s electrical charge and energy balance.

• Jarrod discusses testing involving buccal cells that he says demonstrated measurable changes in cellular electrical conductivity.

• Quantum-imprinted copper vessels are discussed as a way of transferring energy to drinking water.

• The Light System smartwatch incorporates a quantum-charged stainless-steel band and coded affirmations.

• The episode explores the relationship between mindset, intention, the placebo effect, and physiological responses.

“Everything around us is made up of frequency… those frequencies exist, whether heard or not heard.”

“By restructuring the water within our bodies, we are restructuring the energy flow within our body.”

“When those photons leave each opposing monitor, they collide right in the center… and that collision creates a burst of energy.”

“Instead of replenishing our energy tank through food… we need to expel more energy to get toxins out.”

“If we can free up those blockages or make the flow of energy more efficient… then our body will be in a better place.”

“We are giving the body more tools… elevating the electrical charge so the body is in a better place to do what it knows how to do.”

“The mind is that powerful that if it truly believes something, then your body will follow.”

00:00:00 — Introduction to The Energy Code & Jarrod Barakett 00:01:56 — Jarrod’s Background: Mindset, Agronomy & Cannabis Industry 00:03:46 — Severe Spinal Injury & Rapid 10-Week Recovery 00:07:50 — History & Origins of The Light System 00:10:39 — Mindset, Business Leadership & Energetic Principles 00:11:08 — Mid-Roll: Methylene Blue & Bio Blue Promotion 00:14:56 — Sacred Geometry, Spheres & Cubes 00:16:30 — Cellular Water, Frequency & Words 00:20:06 — Restructuring Energy Flow & Cellular Blockages 00:23:12 — Polychromatic Therapy & Bio-Photonic Collisions 00:26:06 — Cellular Voltage & Modern Environmental Toxins 00:30:49 — Jarrod’s Unconventional Recovery & Surgeon’s Reaction 00:34:31 — Buccal Cell Electrical Conductivity Research 00:36:03 — Quantum-Charged Water Bottles & Jewelry 00:37:39 — EMF Protection & The Quantum Smartwatch 00:43:11 — Testimonials & Real-World Experiences 00:44:36 — Product Breakdown: Pyramid Mini, Cubes & Dual-Cube Setups 00:47:08 — Product Placement: Garages, Bedrooms & Sleep 00:48:57 — Fibonacci Geometry, Cellular Voltage & Mitochondria 00:50:38 — Cleanses, Fasting & Glutathione 00:53:11 — Mental Health, Personal Tragedy & Resilience 00:56:58 — The Placebo Effect & Mind-Body Healing 00:58:57 — Rapid Fire: Sunlight, Frequency & Future Technologies 01:06:00 — Peptide Research: Follistatin, Klotho & Future Medicine 01:11:58 — Where to Find The Light System & Closing Remarks

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Along the way, Dr. Mike explains what each study found, why it matters, where the science is headed, and what these discoveries reveal about the central role mitochondria play in virtually every aspect of human health. From glyphosate toxicity to Humanin, MOTS-c, Urolithin A, mitophagy, and the future of mitochondrial transplantation, this episode is packed with practical insights and exciting developments from the forefront of mitochondrial medicine.

(Educational content only, not medical advice.)

-

Articles Discussed in Episode:

1. Effects of Glyphosate and Roundup® Herbicides on Cardiac and H9c2 Cells' Mitochondrial Respiration and Oxidative Stress

2. Sex Differences in Mitochondrial Function: Endocrine Regulation, Immunometabolic Signaling, and Implications for Health and Disease

3. Targeting Mitochondrial Dysfunction to Quell Neuroinflammation in the Central Nervous System: A New Strategy for Treating Central Nervous System Disease with Nanomedicines

4. Cholesterol in Mitochondrial Diseases: Friend or Foe?

5. Mitigating Mitochondrial Dysfunction: A Novel Strategy for Chinese Botanical Drugs Against Osteoporosis

6. Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction

7. The Gut Microbiome and Mitochondrial Function in Metabolism, Immunity, and Disease

8. Urolithin A Activates Mitophagy via the AMPK-mTOR Axis and Modulates the Gut-Ceramide Axis to Ameliorate Cardiac Remodeling in HFpEF

9. Mitophagy Deficiency and Calcium Dyshomeostasis Underlie the Pathogenesis and Progression of Alzheimer's Disease

10. Patient's Own Mitochondria Injected Into Eyes in Attempt to Restore Vision

-

Key Quotes From Dr. Mike:

"Roundup appears far more damaging to cardiac mitochondria than glyphosate by itself."

"Mitochondria are essential signaling hubs linking endocrine health, immune function, and metabolism."

"Mitochondrial dysfunction may be one of the primary drivers of neuroinflammation."

"Cholesterol may actually be acting as a compensatory response to mitochondrial stress."

"Lower Humanin and MOTS-c levels correlated with more severe atrial fibrosis."

"Mitophagy continues to emerge as one of the most important longevity pathways."

"Alzheimer's disease may be fueled by both mitophagy failure and calcium dysregulation."

"Scientists have now injected a patient's own mitochondria into the eye."

"Virtually every paper we discussed comes back to improving bioenergetics."

-

Key Points

⚡ This episode features a rapid-fire review of ten newly published mitochondrial research papers across multiple areas of health.

⚡ Commercial Roundup appears substantially more toxic to cardiac mitochondria than glyphosate alone, highlighting the importance of herbicide co-formulants.

⚡ Mitochondrial function differs significantly between men and women due to hormonal regulation throughout life.

⚡ Mitochondrial dysfunction may be a central driver of neuroinflammation and numerous neurological diseases.

⚡ Cholesterol may play a far more complex role in mitochondrial disease than previously appreciated.

⚡ Chinese botanical medicines may support osteoporosis by improving mitochondrial biogenesis, dynamics, and mitophagy.

⚡ Humanin and MOTS-c demonstrated promising effects in reducing atrial fibrosis and atrial fibrillation in preclinical research.

⚡ The gut microbiome may influence health primarily through its effects on mitochondrial resilience rather than microbial composition alone.

⚡ Urolithin A continues to demonstrate impressive mitophagy-promoting effects while improving heart function in heart failure models.

⚡ Alzheimer's disease progression appears closely linked to impaired mitophagy and disrupted calcium homeostasis.

⚡ Researchers successfully transplanted a patient's own mitochondria into the eye, demonstrating safety and temporary physiological improvements.

⚡ Mitochondrial transplantation could become one of the next major frontiers in regenerative medicine.

⚡ Throughout nearly every study, improved mitochondrial quality control, energy production, and bioenergetics emerged as common therapeutic themes.

-

Episode timeline

• Introduction: Research Jamboree Format
• BioLight Instagram Update & Free Speech Discussion
• Roundup vs. Glyphosate and Cardiac Mitochondria
• Sex Differences in Mitochondrial Function
• Mitochondria and Neuroinflammation
• Cholesterol's Role in Mitochondrial Disease
• Chinese Botanical Medicines & Osteoporosis
• Humanin + MOTS-c for Atrial Fibrillation
• Gut Microbiome & Mitochondrial Resilience
• Urolithin A for Heart Failure
• Mitophagy & Alzheimer's Disease
• Mitochondrial Transplantation to Restore Vision
• Final Thoughts & Future of Mitochondrial Medicine

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this episode, Dr. Mike Belkowski breaks down the science behind 14 different intranasal peptide formulations, explaining how the nasal cavity may provide a unique pathway to the brain through the olfactory and trigeminal nerves while partially bypassing the blood-brain barrier.

From cognitive enhancement and stress resilience to mitochondrial function, neuroprotection, sleep, circadian biology, traumatic brain injury, neuroinflammation, and healthy brain aging, this episode explores the proposed mechanisms and emerging research behind today's most talked-about intranasal peptides.

Dr. Mike reviews the evidence behind Semax, Selank, SS-31, MOTS-c, Humanin, Epitalon, Pinealon, BPC-157, KPV, DSIP, Oxytocin, and three novel peptide blends while emphasizing where the science is strongest — and where it's still highly theoretical.

Whether you're interested in brain health, mitochondrial medicine, longevity, or peptide science, this episode serves as one of the most comprehensive overviews available on intranasal peptide research.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

"The nasal cavity provides one of the most unique access points we have to the central nervous system."

"Intranasal delivery isn't magic — but for the right peptide, it may dramatically change where that peptide goes."

"Semax is the accelerator, Selank is the stabilizer... One improves focus, the other improves calm."

"Humanin may be one of the most exciting mitochondrial-derived peptides for brain recovery."

"BPC-157 may be far more interesting for brain injury than most people realize."

"KPV isn't just an anti-inflammatory peptide — it may become a neuroinflammatory peptide."

"Oxytocin isn't simply the 'love hormone' — it's deeply involved in stress circuitry."

"Brain health is ultimately an energy problem before it becomes a disease problem."

-

Key Points

⚡ Intranasal peptide delivery may provide direct access to the central nervous system through the olfactory and trigeminal pathways while partially bypassing the blood-brain barrier.

⚡ Unlike oral peptides, intranasal delivery avoids gastrointestinal degradation and first-pass liver metabolism.

⚡ Not every peptide is suitable for intranasal delivery — molecular size, stability, formulation, and nasal absorption all influence effectiveness.

⚡ Semax remains one of the most extensively studied intranasal peptides for cognition, neuroplasticity, and neuroprotection.

⚡ Selank is primarily researched for anxiety reduction, stress resilience, calm focus, and GABA-related signaling.

⚡ Combining Semax and Selank may provide complementary support for focus, learning, emotional regulation, and stress resilience.

⚡ SS-31 targets cardiolipin within mitochondria, making it one of the most unique mitochondrial peptides for neuronal energy production.

⚡ MOTS-c supports metabolic adaptation, mitochondrial resilience, and recovery following neurological stress.

⚡ An SS-31 + MOTS-c blend may offer one of the strongest theoretical approaches for mitochondrial brain support.

⚡ Humanin restores mitochondrial bioenergetics and synaptic function following traumatic brain injury in preclinical research.

⚡ Epitalon primarily targets circadian biology, pineal signaling, and healthy aging rather than acute cognitive enhancement.

⚡ Pinealon focuses more directly on cognition, neuroprotection, and neuronal resilience.

⚡ Combining Epitalon with Pinealon creates a longevity-focused formulation targeting both circadian biology and cognitive aging.

⚡ BPC-157 may have intriguing applications for traumatic brain injury, vascular integrity, and neuronal recovery.

⚡ KPV appears particularly promising for neuroinflammation and microglial regulation.

⚡ DSIP centers around restorative sleep, stress recovery, hypoxia tolerance, and mitochondrial support.

⚡ Oxytocin has one of the largest bodies of intranasal research for stress regulation, PTSD, emotional processing, and social cognition.

⚡ Many of these proposed applications remain mechanistic or preclinical and require substantially more human clinical research.

⚡ Rather than targeting neurotransmitters alone, many of these peptides aim to improve mitochondrial function, cellular resilience, inflammation, and recovery.

⚡ The episode concludes with a practical framework that categorizes every peptide by its primary research focus — from repair and inflammation to focus, calm, mitochondrial resilience, and longevity.

-

Episode timeline

00:00 — Introduction: Why Intranasal Peptides?

04:30 — How Nose-to-Brain Delivery Works

07:15 — Semax

11:12 — Selank

15:00 — Semax + Selank

17:10 — SS-31

22:40 — MOTS-c

26:40 — SS-31 + MOTS-c

28:24 — Humanin

31:50 — Epitalon

35:08 — Pinealon

37:25 — Epitalon + Pinealon

39:18 — BPC-157

45:52 — KPV

48:28 — DSIP

53:27 — Oxytocin

57:06 — Final Review & Best Use Cases

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this episode of The Energy Code, Dr. Mike Belkowski reviews three newly published studies that, when viewed together, point toward an emerging concept he calls the mitochondria-metabolism-brain axis.

The first paper explores how GLP-1 medications may influence mitochondrial biology beyond weight loss by interacting with pathways involved in mitochondrial biogenesis, oxidative stress, and cellular resilience. The second investigates how Urolithin A restored mitophagy and eliminated anxiety-like behavior in animal models. The third demonstrates how Urolithin B improved depression-like behavior by activating mitochondrial quality-control pathways through SLP2 and the PINK1/Parkin signaling system.

While much of the evidence remains preclinical, the convergence across these independent research groups is striking.

Rather than focusing on three different diseases, the episode explores one shared biological thread: mitochondrial quality control.

If these findings continue to translate into humans, they could fundamentally reshape how we think about metabolism, aging, inflammation, resilience, and brain health.

(Educational content only, not medical advice.)

-

Articles Discussed in Episode:

The GLP-1–Mitochondria Axis in Metabolic Aging

Urolithin A Abolishes High Anxiety and Rescues the Associated Mitochondria-Related Transcriptomic Signatures and Synaptic Function

Urolithin B Ameliorates Depressive-Like Behavior and Hippocampal Neuronal Damage in Depressed Rats via Regulation of the SLP2/PINK1/Parkin Signaling Pathway

-

Key Quotes From Dr. Mike:

"The real question isn't whether one of these compounds works — it's whether we're uncovering a broader mitochondria-metabolism-brain axis."

"Mitochondrial dysfunction sits at the center of metabolic aging."

"GLP-1 drugs may be touching the exact mitochondrial machinery that declines with age."

"Urolithin A didn't simply reduce anxiety — it appeared to restore the mitochondrial quality control system underlying it."

"Urolithin B improved behavior, protected hippocampal neurons, and reduced neuroinflammation."

"Mitochondrial quality control may be one of the shared nodes connecting metabolism, aging, inflammation, and the brain."

"The mitochondrion is beginning to look less like a power plant and more like a resilience hub."

-

Key Points

⚡ Three newly published studies explored metabolic aging, anxiety, and depression—but all converged on mitochondrial biology as a shared mechanism.

⚡ The episode introduces the emerging concept of the mitochondria-metabolism-brain axis.

⚡ A new Aging Cell review proposes that mitochondrial dysfunction sits at the center of metabolic aging.

⚡ Age-related declines in NAD, sirtuins, PGC-1α, mitochondrial biogenesis, and mitophagy may collectively drive metabolic decline.

⚡ GLP-1 receptor agonists may influence mitochondrial function through AMPK, PGC-1α, NRF2, and mitophagy pathways.

⚡ Despite compelling mechanisms, direct mitochondrial benefits of GLP-1 drugs in humans remain an active hypothesis—not established fact.

⚡ Large clinical trials continue to demonstrate significant cardiovascular and metabolic benefits from GLP-1 therapies.

⚡ Neurons have extraordinarily high energy demands, making the brain especially vulnerable to mitochondrial dysfunction.

⚡ A new Biological Psychiatry study found that Urolithin A eliminated anxiety-like behavior in multiple rodent models.

⚡ Urolithin A restored mitochondrial quality control by improving mitophagy through the PINK1/Parkin pathway.

⚡ The anti-anxiety effects occurred without sedation and primarily benefited animals exhibiting high anxiety.

⚡ Urolithin A also restored neuronal connectivity, dendritic complexity, synaptic function, and Mitofusin-2 expression.

⚡ A second study found that Urolithin B significantly improved depression-like behavior in stressed rats.

⚡ Urolithin B reduced neuroinflammation, preserved hippocampal neurons, increased BDNF and serotonin, and lowered corticosterone.

⚡ Researchers identified SLP2 as a key upstream regulator driving PINK1/Parkin-mediated mitophagy.

⚡ Knocking down SLP2 largely eliminated Urolithin B's protective effects, strengthening the proposed mechanism.

⚡ All three papers independently converged on mitochondrial quality control and mitophagy as central biological processes.

⚡ The PINK1/Parkin pathway appeared repeatedly across metabolic aging, anxiety, and depression research.

⚡ Mitochondrial quality control may represent a shared biological node linking seemingly unrelated chronic diseases.

⚡ The most important takeaway isn't any single molecule—it's the growing evidence that mitochondrial resilience may influence multiple organ systems simultaneously.

-

Episode timeline

00:00 – One Question Connects Three Diseases

• Could metabolic aging, anxiety, and depression all share one biological mechanism?

02:30 – The GLP-1 Mitochondrial Axis

• Aging Cell review

• Mitochondrial dysfunction and metabolic aging

• NAD, sirtuins, PGC-1α, mitophagy

• Human vs. animal evidence

16:40 – Why the Brain Depends on Healthy Mitochondria

• Neuronal energy demands

• Why mitochondrial dysfunction disproportionately affects the brain

18:40 – Urolithin A and Anxiety

• Biological Psychiatry study

• Anxiety models

• Mitophagy restoration

• PINK1/Parkin pathway

• Mitofusin-2

27:00 – Urolithin B and Depression

• Brain Research Bulletin study

• SLP2 signaling

• PINK1/Parkin activation

• Hippocampal neuroprotection

• Behavioral improvements

36:30 – The Bigger Picture

• How all three studies converge

• The mitochondria-metabolism-brain axis

• Why mitochondrial quality control may become one of the defining concepts in longevity science

41:30 – Final Takeaways

• • What we know

  • What remains speculative

  • Why this emerging field deserves close attention

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this episode of The Energy Code, Dr. Mike Belkowski breaks down the most important mitochondrial research published over the last month and separates genuine scientific progress from marketing hype.

You'll learn why independent testing revealed that some commercial red light therapy devices don't emit the wavelengths they claim, why that matters far more than advertised power output, and what consumers should actually be looking for.

Dr. Mike also explores the latest mechanistic research on methylene blue, the expanding clinical evidence behind Urolithin A, and a fascinating new body of mitochondrial science suggesting that dysfunctional mitochondria may actively drive inflammation and aging through cellular signaling — not simply by producing less energy.

If the recent science is pointing in one direction, it's this:

Mitochondrial quality may be one of the most important upstream regulators of health, resilience, and longevity.

Whether you're interested in red light therapy, methylene blue, Urolithin A, or simply understanding where longevity science is headed next, this episode provides an evidence-based review of the month's biggest developments.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

"Wavelength is the identity of the treatment... Power output can often be compensated for. Wavelength cannot."

"Consumers should care whether companies are willing to have their products independently tested."

"Methylene blue is not a molecule where more automatically means better."

"Healthy mitochondria don't just make energy. They help determine how your cells respond to stress, inflammation, and aging."

"Every month, the science becomes a little clearer: mitochondrial health sits upstream of countless chronic diseases."

"The best longevity interventions don't replace biology — they help restore how biology was designed to function."

-

Key Points

⚡ Independent researchers tested commercial red light therapy devices with laboratory spectrometers and found that some failed to emit the wavelengths they claimed.

⚡ Wavelength accuracy may be more important than raw power output because wavelength determines the biological target being stimulated.

⚡ FDA Registered, FDA Cleared, and FDA Approved are very different regulatory classifications—and understanding the distinction matters.

⚡ The red light industry is beginning to mature, with manufacturers focusing more on wavelength selection and engineering than simply increasing wattage.

⚡ New mechanistic research continues strengthening our understanding of how methylene blue influences mitochondrial redox biology.

⚡ Methylene blue appears to provide its greatest mitochondrial benefits at lower doses, reinforcing its biphasic dose-response.

⚡ Safety remains paramount with methylene blue, particularly regarding serotonergic medications, dosing, and product purity.

⚡ Urolithin A continues expanding beyond muscle health into immune aging, obesity, cognition, oncology, and metabolic health.

⚡ A new Nature Aging study explored how Urolithin A may support immune function by improving mitochondrial quality control through mitophagy.

⚡ Researchers are now investigating whether Urolithin A can help preserve lean muscle mass during weight loss, particularly alongside GLP-1 therapies.

⚡ Emerging mitochondrial research suggests damaged mitochondria actively communicate with the nucleus, influencing inflammatory gene expression and aging.

⚡ Mitochondria are increasingly being viewed as drivers of inflammation — not simply victims of aging.

⚡ New research highlights the importance of mitochondrial membranes, network dynamics, and respiratory supercomplex architecture in maintaining cellular energy production.

⚡ Controlled mitochondrial stress (hormesis) continues to emerge as one of the body's most powerful mechanisms for building resilience.

⚡ The month's research reinforces that mitochondrial quality—not simply mitochondrial quantity — may be one of the most important upstream regulators of healthspan and longevity.

⚡ While supplements and therapies continue to advance, the highest-leverage mitochondrial interventions remain the fundamentals: quality nutrition, exercise, sleep, metabolic health, and consistent healthy habits.

⚡ Red light therapy, methylene blue, and Urolithin A should be viewed as tools that amplify a strong biological foundation — not replace one.

-

Episode timeline

• The biggest red light story wasn't a new device—it was independent testing.
• Overview of the month's biggest mitochondrial research.

• Independent wavelength verification.
• Why wavelength accuracy matters more than marketing wattage.
• Devices that passed—and those that didn't.

• FDA Registered vs FDA Cleared vs FDA Approved.
• Why consumers should understand the difference.

• New mitochondrial mechanisms.
• Redox biology.
• Why dose remains everything.

• Nature Aging publication.
• Immune aging.
• Muscle preservation during weight loss.
• Obesity and cognition research.

• Mitochondria communicate with the nucleus.
• Inflammation and aging may begin upstream in mitochondrial dysfunction.
• Why this changes how we think about longevity.

• Choosing red light devices.
• Methylene blue expectations.
• Why Urolithin A continues gaining momentum.
• The importance of foundational lifestyle interventions.

• Future red light testing.
• Traumatic brain injury research.
• Urolithin A clinical expansion.
• Mitochondrial signaling and epigenetics.

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

“Good for people and good for the planet has always been my mantra.”

“Nature is still one of the greatest technologies we’ve ever had.”

“The future of wellness is frequencies, energies, and intuition.”

“I don’t feel like I lived if I didn’t learn something new every day.”

“I try to create one hero moment every single day.”

⚡ David Horinek returns to discuss the latest innovations he’s developing across biohacking, sustainable materials, and frequency-based health technologies.

⚡ Morning sunlight, grounding, and time in nature remain foundational health practices despite rapidly advancing wellness technologies.

⚡ Infrared-responsive materials continue expanding into clothing, bedding, topical products, agriculture, and construction materials.

⚡ Violet-light technologies may become a future tool for food preservation and biological applications.

⚡ David believes light, sound, and frequency therapies represent one of the next frontiers in health optimization.

⚡ The conversation explores how mitochondrial function and peptide production may be more closely connected than previously understood.

⚡ Emerging peptide delivery systems may reduce reliance on injectable therapies through improved absorption technologies.

⚡ AI and data centers present both opportunities and challenges, including concerns around energy use, noise pollution, infrastructure, and privacy.

⚡ David shares his philosophy on entrepreneurship, intellectual property, intuition, and developing inventions through collaboration.

⚡ Both David and Dr. Mike emphasize small daily habits, spending time outdoors, and continuous learning as long-term strategies for health and success.

⚡ The episode concludes with a rapid-fire Q&A covering David’s favorite inventions, biggest inspirations, and vision for the future of wellness.

00:00:00–00:02:47 — Mike introduces David Horinek and the evolution of BioBlue and BioCream

00:02:48–00:06:02 — Morning sunlight, circadian biology, infrared energy, and David’s early influences

00:06:03–00:10:58 — Frequency agriculture, sustainable textiles, AI-assisted farming, and NASA-inspired research

00:10:59–00:15:00 — Building cellular homeostasis with light, sound, and mitochondrial support

00:15:01–00:18:00 — Red light therapy, eye health, nutrition, and daily longevity practices

00:18:01–00:22:48 — Grounding, forest immersion, and reconnecting with nature

00:22:49–00:25:50 — Chaga, sea buckthorn, functional nutrition, and BioCream

00:25:51–00:35:45 — Cold exposure, active building materials, BioLight innovations, and longevity technologies

00:35:46–00:45:56 — Functional beverages, women’s health products, future inventions, and entrepreneurial updates

00:45:57–00:49:10 — Intellectual property strategies, collaborative innovation, and violet-light food preservation technologies

00:49:11–00:54:30 — The future of peptides, blockchain applications, digital ownership, and decentralized technologies

00:54:31–01:04:38 — AI, data centers, sustainable infrastructure, meditation, float therapy, and creativity

01:04:39–01:12:17 — Mitochondria, peptide signaling, bioenergetics, photonic amino acids, and the future of frequency medicine

01:12:18–01:19:58 — Practitioner philosophy, resilience, daily habits, Kaizen, grounding, and peptide delivery innovations

01:19:59–01:23:31 — Rapid-fire questions: favorite inventions, wellness technologies, inspiration, and the future of health

01:23:32–End — Where to follow David, upcoming projects, final thoughts, and closing remarks

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this wide-ranging conversation, Dr. Mike Belkowski sits down with Kris Gethin to explore the practical side of biohacking — from travel optimization and circadian health to grounding, light exposure, peptides, longevity, and why intuition may be just as important as technology.

Chris shares his personal peptide journey, including how BPC-157, TB-500, GHK-Cu, and cartilage-targeting peptides dramatically accelerated his recovery after major injuries. He also discusses the current peptide landscape, how to identify reputable sources, and where he believes the industry is headed.

The conversation ultimately comes back to a simple but powerful message: the greatest health interventions are often the foundational ones — movement, sunlight, nature, sleep, and consistency.

(Educational content only, not medical advice.)

-

Articles & Books Discussed in Episode:

• Books by Kris Gethin: 12-Week Daily Video Trainer, The Bodybuilding.com Guide to Your Best Body, and Man of Iron

• Research & References: Peptide Signaling and Tissue Bioregulators Study, Environmental Psychology of View Angles and Cortisol Reduction, Methylene Blue Cellular Energy Research

-

Key Quotes From Kris:

• “Health optimization requires continuous daily mobility, not just an intense hour in the gym.”

• “If you over-quantify every single biological metric, you end up inducing the very stress you're trying to eliminate.”

• “Grounding and nature offer a biological reset that no expensive technology can replicate.”

• “Peptides provide the body with precise cellular directions, but sourcing and third-party testing are non-negotiable.”

• “Sleep quality will always trump sleep duration if your environment isn't dialed in.”

-

Key Points

⚡ Kris Gethin joins Dr. Mike Belkowski for a treadmill-desk session focused on practical health optimization and high-performance recovery.

⚡ Continuous daily movement and mobility take precedence over isolated workout sessions for long-term metabolic health.

⚡ Combatting travel-induced oxidative stress requires proactive pre-, during-, and post-flight protocols.

⚡ Key travel non-negotiables include Faraday shielding, blue-light blocking glasses, and grounding techniques to maintain circadian balance.

⚡ Earth grounding and spending time in natural settings trigger immediate stress reduction and biological recovery.

⚡ Over-reliance on health tracking devices can cause "shiny object syndrome" and distract from listening to internal body cues.

⚡ Tissue-specific bioregulator peptides like BPC-157 and TB-500 aid in targeted cell signaling for injury recovery and repair.

⚡ The peptide industry faces significant hurdles with FDA scrutiny, payment processing issues, and gray-market quality concerns.

⚡ Independent, third-party lab testing is essential for consumers looking to verify peptide purity and authenticity.

⚡ Methylene blue serves as an effective intervention for enhancing cellular energy and mitochondrial function.

⚡ Optimizing sleep architecture relies on environmental controls like total blackout light elimination, air filtration, and active cooling.

⚡ Sleep duration matters far less than sleep quality and uninterrupted deep/REM cycles tailored to individual needs.

-

Episode Timeline

• 00:00:02–00:00:34 — Show Intro: Unlocking the Mitochondrial Matrix

• 00:00:35–00:03:00 — Welcome back Kris Gethin & treadmill desk catch-up

• 00:03:01–00:04:09 — The importance of continuous daily movement over isolated workouts

• 00:04:10–00:07:10 — Authenticity and mentorship in the health and wellness industry

• 00:07:11–00:13:14 — Pre-, during-, and post-travel protocols to mitigate oxidative stress and jet lag

• 00:13:15–00:16:48 — Mid-episode spotlight: Methylene blue and cellular energy boost

• 00:16:49–00:17:59 — Top 3 travel non-negotiables: Faraday blankets, grounding footwear, and blue-blocking glasses

• 00:18:00–00:22:24 — The overlooked biological power of earthing and grounding

• 00:22:25–00:28:16 — Nature as nurturing medicine: Environmental psychology and view angles

• 00:28:17–00:32:14 — Sifting through biohacking noise: Fraud, over-testing, and shiny object syndrome

• 00:32:15–00:37:59 — Balancing data quantification with intuitive bodily awareness

• 00:38:00–00:43:42 — Deep dive into peptides: Origins, injury recovery, and tissue regeneration

• 00:43:43–00:47:31 — Industry challenges: Payment processing, FDA scrutiny, and gray market quality control

• 00:47:32–00:52:11 — Consumer advice for sourcing peptides and performing independent lab testing

• 00:52:12–01:02:44 — Comparing peptides to traditional pharmaceuticals and life-extending signaling

• 01:02:45–01:04:59 — Emerging peptides: Klotho proteins, myostatin inhibitors, and new delivery methods

• 01:05:00–01:12:01 — Analysis of extreme health tracking and avoiding performance anxiety in biohacking

• 01:12:02–01:17:22 — Upgrading sleep architecture: Blackout shades, Chilly Pad temperature control, and air filtration

• 01:17:23–01:20:06 — Sleep hours vs. sleep quality: Individualized sleep architecture

• 01:20:07–01:25:30 — Unmatched Longevity Sleep: Ingredient synergies and supporting natural sleep hygiene

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

On July 23–24, the FDA’s Pharmacy Compounding Advisory Committee considered seven widely discussed peptides and voted in favor of six: BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax, while rejecting DSIP (emideltide).

But these votes are widely misunderstood.

In this Energy Code Deep Dive, Dr. Mike Belkowski breaks down what the committee actually voted on, why a YES vote is not FDA drug approval, and the debate that divided the committee: should promising but under-studied peptides remain largely in the gray market, or could regulated pharmacy compounding provide a safer path?

We explore the harm-reduction argument behind the YES votes, the FDA scientists’ objections, concerns surrounding human evidence, product consistency and immunogenicity, why DSIP failed to clear the bar, and what happens next.

This isn't the finish line for peptides. But it could represent a major turning point in how peptide medicine is researched, regulated, and ultimately accessed.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

“Six of the seven (peptides) got a thumbs up. One got rejected.”

“A yes vote didn't mean the FDA is declaring the peptide safe and effective.”

“The yes side is saying, ‘Meet people where they are and add safety guardrails.’”

“The no side says, ‘Thin evidence is thin evidence, and a regulatory blessing shouldn't get ahead of the science.’”

“The single best thing that could come out of this moment is that the mainstreaming of peptides drives real rigorous clinical research.”

-

Key Points

⚡ An FDA advisory committee voted favorably on 6 of 7 peptides considered for the 503A compounding pathway.

⚡ BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax received favorable recommendations; DSIP did not.

⚡ These votes do not constitute FDA drug approval and are non-binding recommendations.

⚡ One of the strongest arguments for inclusion was harm reduction: moving peptide use away from unregulated gray-market sources and toward clinicians and licensed pharmacies.

⚡ FDA scientists opposed inclusion, citing limited human evidence, product-characterization issues, immunogenicity concerns, and the possibility of creating false perceptions of FDA endorsement.

⚡ The BPC-157 vote was particularly close: 8–6 with one abstention.

⚡ DSIP was rejected amid especially limited evidence and questions surrounding the proposed route of administration.

⚡ The composition of the advisory committee and potential industry conflicts became another source of controversy.

⚡ Even if ultimately permitted for compounding, these products would remain fundamentally different from FDA-approved drugs.

⚡ The larger opportunity may be increased legitimacy driving better human clinical research into peptides.

-

Episode timeline

00:00 — A major moment for peptide medicine Why the July FDA advisory committee meeting deserves attention.

01:28 — What the FDA actually voted on The crucial difference between FDA drug approval and inclusion on the compounding bulks list.

04:20 — Nothing changed overnight Why the committee's recommendations are non-binding and what happens next.

04:55 — Peptides 101 & the gray-market problem Why peptide popularity has outpaced human clinical evidence and regulation.

06:27 — The final tally: 6 YES, 1 NO BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax versus DSIP.

08:12 — Breaking down the six peptides What each peptide is commonly associated with and why they're attracting attention.

10:05 — Why the YES side won The central harm-reduction argument: people are already using peptides, so would regulated access be safer?

12:17 — Why FDA scientists opposed all seven Human evidence, consistency, immunogenicity and the danger of perceived regulatory endorsement.

15:15 — Why DSIP failed What the committee's lone rejection reveals about its evidentiary threshold.

16:45 — Politics & conflicts of interest The political environment surrounding the meeting and questions about the panel's composition.

18:52 — What this means for consumers right now Why these votes do not suddenly make the peptides FDA-approved or broadly legal.

20:39 — A legitimacy inflection point Why peptide medicine may be transitioning from a fringe conversation toward the mainstream.

21:15 — The research opportunity Why regulatory momentum still cannot substitute for rigorous human clinical trials.

22:19 — Final takeaways Why this is the beginning of the peptide conversation—not the finish line.

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this episode of The Energy Code, Dr. Mike Belkowski welcomes Dr. John Douillard for a wide-ranging conversation connecting ancient Ayurvedic medicine with modern physiology, mitochondria, circadian biology, digestion, lymphatic health, breathing, seasonal nutrition, and longevity.

Dr. Douillard explains why digestion may be one of the true foundations of health, how the diaphragm powers the body's lymphatic system, why modern lifestyles disconnect us from natural biological rhythms, and why whole foods often outperform isolated compounds. Together they explore the science behind seasonal eating, breathing techniques, microbiome diversity, infrared light, melatonin, circadian medicine, and how aligning with nature may optimize energy production at the cellular level.

Whether you're interested in mitochondria, performance, longevity, nutrition, or foundational health, this conversation bridges thousands of years of traditional wisdom with emerging scientific research.

(Educational content only, not medical advice.)

• Books by Dr. John Douillard: Eat Wheat, The 3-Season Diet, and Body, Mind, and Sport

• Research & References: Stanford Mummy Microbiome Diversity Study, International Journal of Neuroscience Nose-Breathing Study, Breath by James Nestor

“Rasa is the word for lymph. The study of the lymphatic system for Ayurveda was the study of longevity.”

“If you can’t get the trash out of this body, you’re not going to be able to get the good stuff in.”

“80% of your immune response is linked to these foods that create an immune response. If you bubblewrap your diet, you don't have a reason for gut immunity.”

“When you add the plant and its natural microbiome, there’s nothing more potent than that, because it has the intelligence along with the biochemistry.”

“The bigger the calm you have on the inside, the more powerful the winds you have on the outside.”

“Melatonin is a 3-billion-year-old molecule. It isn’t a hormone... It tells your body when nighttime and winter are coming.”

⚡ Dr. John Douillard shares his origin story from competitive triathlon training to studying ancient Ayurvedic medicine at a hospital in India.

⚡ In Ayurveda, Rasayana (longevity) is fundamentally tied to the study and health of the lymphatic system.

⚡ The lymphatic system handles waste removal, immune cell transportation, and baseline delivery of dietary fatty acid precursors for hormone production.

⚡ The diaphragm is the primary mechanical pump for both the body's lymphatics and the brain’s glymphatic waste-clearance system.

⚡ Studies reveal that 91% of elite athletes tested do not possess fully contracting and relaxing diaphragms due to chronic stress patterns.

⚡ Incompletely digested proteins and fats escape into the intestinal lymphatic collecting ducts, triggering systemic inflammation, brain fog, and skin eruptions.

⚡ "Bubble-wrapping" the diet by completely eliminating slightly irritating foods (like gluten, lectins, or nightshades) starves the gut of the hormetic irritation required for robust gut immunity.

⚡ Long-term continuous ketogenic diets bypass seasonal evolutionary biological cues, whereas seasonal fat-burning aligns with natural spring scarcity.

⚡ Dr. John demonstrates a step-by-step Maximum Inspiratory Breathing technique to break up rib cage scar tissue and reactivate full diaphragmatic movement.

⚡ Five key spices—ginger, cumin, coriander, fennel, and cardamom—naturally stimulate stomach acid, bile flow, pancreatic enzymes, and healthy gut microbes.

⚡ Cooking meat and foods with whole spices mitigates the free radical damage and carcinogenic compounds produced by high heat.

⚡ Whole turmeric root outperforms isolated curcumin extracts because isolated extracts can block stem cell production, whereas the full plant supports it.

⚡ Early morning sunlight exposures balance daytime and nighttime biological clocks while fueling mitochondrial cytochrome c oxidase and ATP production.

⚡ Front-loading food intake into breakfast and lunch matches human biological digestive clocks better than eating large late-night dinners.

⚡ Only 10% of total body melatonin originates in the pineal gland for sleep; 90% is produced within cellular mitochondria via infrared light exposure to neutralize metabolic free radicals. ⚡ DNA releases ultra-weak biophoton emissions that become coherent during calm, meditative states, carrying cellular information and systemic intention.

⚡ Microdosing melatonin supports cellular waste cleanup without suppressing the body's natural endogenous production.

⚡ Pushing energy production (e.g., via high-dose NAD+ precursors) without first clearing cellular trash and supporting lymphatic drainage can exacerbate systemic stress.

⚡ Nasal breathing during physical exertion shifts the brain into a calm alpha state, permitting parasympathetic recovery to coexist alongside high physical output.

• 00:00–02:14 — Introduction: Dr. John Douillard's background in sports medicine, Ayurveda, and chiropractic care

• 02:15–06:50 — Origin story: Ironman triathlons, meditation retreats, and studying medicine in India

• 06:51–09:33 — Longevity and Rasayana: The vital role of the lymphatic system

• 09:34–13:50 — Diaphragm as the lymph pump, brain waste clearance, and systemic consequences of poor digestion

• 13:51–18:42 — The "bubble-wrapped diet" trap vs. seasonal eating and circadian alignment

• 18:43–21:11 — BioLight sponsorship spot

• 21:12–25:22 — Diaphragmatic weakness, chronic stress, and restoring digestive strength

• 25:23–28:37 — Live Demonstration: Maximum Inspiratory Breathing technique

• 28:38–32:10 — The 5 digestive spices that reboot stomach acid and protect against cooking toxins

• 32:11–36:35 — Plant micro-intelligence vs. sterile extracts, and soil microbiome changes across 3 seasons

• 36:36–41:00 — Fixing the root cause of digestion instead of blaming food

• 41:01–45:06 — Ayurvedic seasonal grocery lists (Vata, Pitta, Kapha balancing)

• 45:07–48:40 — Whole turmeric root vs. isolated curcumin extracts

• 48:41–53:29 — Circadian light habits, morning UV/infrared rays, and meal timing

• 53:30–57:10 — Seasonal sleep dynamics, activity cycles, and ancient alignment

• 57:11–01:05:14 — Quantum Ayurveda: Biophoton light emissions, sub-cellular melatonin, and creating inner stillness

• 01:05:15–01:13:38 — Mitochondrial waste removal, microdosing melatonin, and systemic anti-inflammation

• 01:13:39–01:16:58 — Practical lymphatic hacks: Exfoliation, static electricity, hydration, and movement

• 01:16:59–01:25:28 — Coaching the NBA's New Jersey Nets: Nasal breathing research vs. mouth breathing in elite athletics

• 01:25:29–01:27:08 — Peptide therapy perspectives, regulation, and closing quick-fire thoughts

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

The first study followed Division I football players across a full season and found that athletes using 810-nanometer transcranial and intranasal light maintained greater stability in MRI markers associated with neuroinflammation and axonal stress. The second study used 1,064-nanometer light over the right prefrontal cortex and reported improved impulse control, increased prefrontal oxygenation, and a 51% improvement in correct response inhibition among participants with ADHD after a single session.

Although both studies are early and carry important limitations, they point toward the same underlying principle: brain health, resilience, and cognitive performance are deeply dependent on bioenergetics. Whether the goal is protecting the brain from repeated trauma or improving executive function, supporting mitochondrial energy production, oxygenation, and inflammatory balance may be the common lever.

(Educational content only, not medical advice.)

-

Articles Discussed in Episode:

Transcranial Photobiomodulation Promotes Neurological Resilience in Current Collegiate American Football Players Exposed to Repetitive Head Acceleration Events

Transcranial photobiomodulation improves prefrontal oxygenation and impulse control in adults with ADHD: a randomized controlled trial

-

Key Quotes From Dr. Mike:

“So much of brain health traces back to whether cells and mitochondria can make and utilize energy efficiently.

“For every diagnosed concussion, hundreds of additional head-acceleration events may be occurring.”

“Can we build resilience into the brain (via red light therapy) before the symptoms ever show up?”

“The (near-infrared) light appeared to help precisely in the areas that needed it most.”

“That improvement brought the ADHD group’s performance up to a level comparable with the non-ADHD participants.”

“A brain with more energy and better oxygen delivery is both more resilient to insult and more capable of performing.”

“Whether the goal is resilience or focus, the same lever keeps showing up: energy production, oxygenation, and inflammation control.”

-

Key Points

⚡ Two new studies examined transcranial photobiomodulation for two very different goals: neuroprotection in football players and cognitive enhancement in adults with ADHD.

⚡ The common mechanism connecting both studies is brain bioenergetics—how efficiently brain cells produce and use energy.

⚡ Red and near-infrared light interact with mitochondrial cytochrome c oxidase, supporting ATP production, oxygen utilization, blood flow, and cellular repair.

⚡ The football study evaluated whether near-infrared light could proactively build neurological resilience across a season of repetitive head impacts.

⚡ For every diagnosed concussion, football players may experience hundreds of additional subconcussive head-acceleration events.

⚡ These repetitive impacts may contribute to neuroinflammation, reduced white-matter integrity, altered brain activation, and cognitive decline.

⚡ The football study included 26 Division I athletes in a randomized, double-blind, sham-controlled design.

⚡ The active protocol used 810-nanometer light pulsed at 40 hertz for 20 minutes, three times weekly across a 16-week season.

⚡ The device targeted nodes of the default mode network and included an intranasal LED for deeper light delivery.

⚡ Diffusion MRI markers associated with neuroinflammation and axonal stress increased across the season in the sham group.

⚡ Players receiving active PBM showed greater stability in those markers and, in some brain regions, measurable reductions.

⚡ The areas showing the strongest protective effects closely matched the brain’s known “cone of vulnerability” to mechanical trauma.

⚡ The football study suggests PBM may help build resilience before cumulative damage becomes symptomatic.

⚡ The ADHD study explored whether near-infrared light could improve function in an underactivated and metabolically underfueled prefrontal cortex.

⚡ The study used 1,064-nanometer laser light over the right prefrontal cortex during a single eight-minute treatment.

⚡ In participants with ADHD, active PBM produced a 51% improvement in correct response inhibition compared with sham treatment.

⚡ Performance improved to a level comparable with participants who did not have ADHD.

⚡ The intervention did not significantly improve performance in the non-ADHD group, suggesting the greatest benefit may occur where a functional deficit exists.

⚡ Functional near-infrared spectroscopy showed increased oxygenated and total hemoglobin in the targeted prefrontal region.

⚡ The behavioral improvements and the biological oxygenation changes occurred in the same targeted area.

⚡ Both studies were early, with small to moderate samples, short timelines, and important methodological limitations.

⚡ The evidence is promising, but larger studies, repeated-session protocols, longer follow-up, and multi-season data are still needed.

⚡ Neuroprotection and cognitive enhancement may be two expressions of the same principle: a better-fueled brain is both more resilient and more capable.

-

Episode timeline

00:00–02:30 — Introduction: two different brain problems, one underlying bioenergetic mechanism

02:32–04:37 — How photobiomodulation affects cytochrome c oxidase, ATP, oxygenation, blood flow, oxidative stress, and inflammation

04:38–06:55 — Study 1 introduction: repetitive head impacts and the need for proactive brain protection in football

06:56–08:35 — Football study design: randomized sham control, 810-nanometer light, 40-hertz pulsing, transcranial and intranasal delivery

08:36–10:09 — Measuring neurological resilience with diffusion MRI, RDI, QA, inflammation, and white-matter integrity

10:10–11:12 — Football study results: rising damage markers in the sham group and relative stability in the active PBM group

11:13–12:11 — The “cone of vulnerability” and why the anatomical pattern of protection matters

12:12–14:00 — Study limitations and why the findings represent an early signal rather than a closed case

14:01–16:55 — Study 2 introduction: adult ADHD, prefrontal hypometabolism, impulse control, and the need for non-drug options

16:56–18:31 — ADHD study stage 1: 1,064-nanometer light, right prefrontal targeting, and the continuous performance task

18:32–19:17 — ADHD study stage 2: working memory testing and real-time measurement of prefrontal oxygenation

19:18–20:30 — Behavioral results: 51% improvement in impulse control after one eight-minute session

20:31–21:47 — Mechanistic results: increased oxygenated blood in the targeted prefrontal cortex

21:48–22:38 — ADHD study limitations, exploratory medication findings, and the need for repeated-session trials

22:39–24:53 — Two populations, two wavelengths, two goals—and the shared mechanism of brain energy

24:54–26:21 — Final takeaways: stronger study designs, calibrated expectations, and brain bioenergetics as the foundation

26:22–27:08 — Closing message and future research to watch

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Traditional multivitamins were designed to prevent deficiency diseases — not to optimize energy, cognition, resilience, or longevity. Dr. Mike explains why many formulas rely on inexpensive nutrient forms, token doses, competing ingredients, and labels with no unifying biological purpose. Vitamin M takes the opposite approach, beginning with one central question: What does a mitochondrion actually need to produce energy and remain resilient?

The episode walks through the formula ingredient by ingredient, organizing Vitamin M into four coordinated systems: replenishing NAD and cellular energy currency, supplying the cofactors required to produce ATP, reinforcing antioxidant defenses, and supporting methylation, DNA repair, and homocysteine management.

Featuring NMN, niacinamide, ubiquinol, active B vitamins, alpha-lipoic acid, taurine, glycine, trace minerals, TMG, and folinic acid, Vitamin M is designed to support sustained cellular energy without caffeine or stimulants. This is not another kitchen-sink multivitamin — it is a coordinated mitochondrial system built from the ground up.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

“Americans spend somewhere north of eight billion dollars a year on multivitamins.”

“Calling these multivitamins expensive urine might actually be too generous.”

“You are only as young as your mitochondria.”

"Mitochondrial health isn't another wellness trend — it's the foundation beneath every wellness trend."

“What does a mitochondrion actually need to make energy and stay resilient? Vitamin M starts with a single question and works backward to the ingredients, forms, and doses.”

"Every ingredient should have a job. Every job should support the same mission."

"Every ingredient in Vitamin M was selected because the mitochondria actually need it — not because the label needed it."

"Mitochondrial health isn't another wellness trend—it's the foundation beneath every wellness trend."

-

Key Points

⚡ Conventional multivitamins were created to prevent deficiency diseases such as scurvy, beriberi, pellagra, and rickets—not to optimize energy or longevity.

⚡ Recommended daily allowances represent minimum deficiency-prevention levels, not necessarily optimal amounts for cellular performance.

⚡ Many traditional multivitamins use inexpensive or inactive forms that the body must convert before they can be utilized.

⚡ Common examples include folic acid instead of bioactive folate, cyanocobalamin instead of active B12, and poorly absorbed mineral oxides.

⚡ Kitchen-sink formulas often contain dozens of ingredients at doses too small to produce meaningful biochemical effects.

⚡ Certain nutrients may also compete for absorption when packed together without an intentional design.

⚡ The central problem with most multivitamins is that they lack a biological thesis or clearly defined system they are built to support.

⚡ Physical energy is fundamentally ATP, and approximately 90–95% of ATP is produced by the mitochondria.

⚡ Mitochondria also regulate hormones, calcium signaling, cellular cleanup, heat production, redox signaling, and programmed cell death.

⚡ Caffeine does not create energy; it temporarily blocks the brain’s perception of fatigue.

⚡ Vitamin M is stimulant-free and is designed to support the machinery that actually produces cellular energy.

⚡ The formula addresses four age-related mitochondrial challenges: declining NAD, inefficient electron transport, weakened mitochondrial quality control, and disrupted methylation.

⚡ Team 1 supports cellular energy currency with NMN and niacinamide to replenish and recycle NAD.

⚡ Team 2 supports ATP production with ubiquinol, active riboflavin, thiamine, pantothenic acid, and mitochondrial adenosylcobalamin.

⚡ Ubiquinol acts both as an electron carrier in the respiratory chain and as a membrane-protective antioxidant.

⚡ Riboflavin supports FAD and FMN, molecules physically required by complexes I and II of the electron transport chain.

⚡ Thiamine helps convert pyruvate into acetyl-CoA, allowing carbohydrate-derived fuel to enter the Krebs cycle.

⚡ Pantothenic acid is required to produce coenzyme A, the carrier that transports fuel from carbohydrates, fats, and proteins.

⚡ Adenosylcobalamin is the mitochondrial form of B12 and helps additional fats and amino acids enter cellular energy pathways.

⚡ Team 3 protects the mitochondrial machinery with alpha-lipoic acid, taurine, glycine, selenium, manganese, and copper.

⚡ Alpha-lipoic acid helps regenerate other antioxidants while also supporting critical Krebs-cycle enzymes.

⚡ Taurine supports mitochondrial membranes, electron-transport proteins, cellular resilience, and healthy aging pathways.

⚡ Glycine supplies a frequently limiting building block for glutathione, the body’s master endogenous antioxidant.

⚡ Selenium, manganese, and copper are required for antioxidant enzymes and mitochondrial respiratory function.

⚡ Team 4 supports methylation and cellular maintenance with TMG, folinic acid, P5P, B12, and glycine.

⚡ Supporting NAD increases methylation demand, so Vitamin M intentionally includes methyl donors and cofactors to replenish that system.

⚡ The formula uses bioavailable forms — including ubiquinol, folinic acid, P5P, adenosylcobalamin, and chelated minerals — rather than inexpensive precursors.

⚡ Vitamin M is designed as two capsules twice daily to provide smoother availability throughout the day.

⚡ Vitamin M pairs naturally with urolithin A for mitophagy and with red light therapy for complementary internal and external mitochondrial support.

-

Episode timeline

00:00–02:25 — Introduction to the launch of Vitamin M and why mitochondrial wellness is foundational to health and longevity

02:27–04:10 — The multivitamin paradox: billions spent annually with underwhelming long-term results

04:11–06:25 — Why multivitamins were created to prevent deficiency diseases—not to optimize vitality, cognition, or aging

06:26–07:34 — The “expensive urine” problem and why wasted nutrients are only part of the issue

07:35–08:56 — Failure 1: Cheap, inactive, or poorly absorbed nutrient forms

08:57–09:37 — Failure 2: Kitchen-sink formulas with token doses and competing nutrients

09:38–10:50 — Failure 3: No biological thesis, target, blueprint, or coordinated system

10:51–13:49 — Why the mitochondria are the correct target for energy, resilience, signaling, and longevity

13:51–15:32 — Caffeine is a loan; ATP is income: stimulation versus genuine cellular energy production

15:33–16:39 — What declines with age: NAD, electron-transport efficiency, mitochondrial cleanup, and methylation

16:40–18:21 — Introduction to Vitamin M and its four coordinated ingredient teams

18:22–21:30 — Team 1: NMN, NAD production, sirtuins, DNA repair, insulin sensitivity, and cellular energy currency

21:32–23:17 — Niacinamide and the NAD salvage pathway: recycling the energy currency already spent

23:19–26:35 — Team 2 begins: ubiquinol, electron transfer, ATP synthase, membrane protection, and CoQ10 biology

26:36–28:01 — Active vitamin B2, FAD, FMN, complexes I and II, and glutathione regeneration

28:03–29:13 — Vitamin B1 as the gateway that allows carbohydrate fuel to enter the Krebs cycle

29:14–30:18 — Vitamin B5 and coenzyme A as the universal fuel-delivery system

30:18–31:29 — Adenosylcobalamin: the mitochondrial form of B12 and expanded fuel utilization

31:31–34:01 — Team 3 begins: oxidative stress, alpha-lipoic acid, antioxidant recycling, and Krebs-cycle support

34:02–35:59 — Taurine, mitochondrial stability, healthy aging, exercise, and cellular resilience

36:01–37:29 — Glycine, glutathione production, oxidative stress, sleep, collagen, and aging

37:31–39:19 — Selenium, manganese, copper, antioxidant enzymes, complex IV, and chelated mineral forms

39:21–41:09 — Team 4: methylation, gene regulation, neurotransmitters, homocysteine, and increased demand from NAD support

41:10–42:00 — TMG as a methyl donor and its role in SAM-e and homocysteine metabolism

42:02–43:00 — Folinic acid, bioactive folate, DNA synthesis, repair, and the one-carbon cycle

43:01–44:23 — P5P, trans-sulfuration, neurotransmitters, glutathione, and the complete methylation system

44:25–47:09 — The full formula: four coordinated teams, synergy, bioavailable forms, and why Vitamin M differs from a conventional multivitamin

47:10–48:51 — Practical use, split dosing, stimulant-free energy, expected experience, and stacking with BioLithin

48:52–49:36 — Vitamin M and red light therapy: “light from the outside, fuel from the inside”

49:37–50:44 — Closing message: moving beyond deficiency prevention toward intentional mitochondrial optimization

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

The episode begins with a recent review exploring how the success of GLP-1 drugs helped normalize self-injection and created an “Ozempic halo” around experimental peptides. Dr. Mike breaks down the digital peptide exposure pathway, the legal fiction of research-use-only labels, the risks of informal titration, and why a certificate of analysis may not confirm sterility, endotoxin safety, potency, or the quality of the vial actually being used.

The second half turns to the FDA Pharmacy Compounding Advisory Committee’s July 23–24 review of BPC-157, KPV, TB-500, MOTS-c, DSIP, Semax, and Epitalon for possible inclusion on the Section 503A Bulks List. Dr. Mike explains what the proceeding does — and does not — mean, the FDA staff’s preliminary opposition, and three possible outcomes: favorable inclusion, rejection, or a substance-by-substance split decision.

Ultimately, the central question is not whether peptide experimentation will continue. It is whether it will occur through accountable medical systems that improve testing and surveillance — or move further into an anonymous gray market operating beyond meaningful oversight.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks

-

Key Quotes From Dr. Mike:

“(Peptides) are relatively safe in the right hands — but can you really trust the sourcing and the quality?”

“A certificate of analysis may be a veneer of professional legitimacy that lacks depth.”

“A high purity percentage does not necessarily tell you about endotoxins, sterility, degradation, or the specific vial in your refrigerator.”

“This (upcoming FDA approval hearing) not an FDA approval hearing for these peptides.”

“What it could mean is that certain peptides gain a pathway into a more regulated, clinician-directed compounding environment.”

“The committee must navigate the uncomfortable space between promising but incomplete science and the responsibility to protect patients.”

“A restrictive decision may reduce access through licensed pharmacies without eliminating consumer demand.”

“The organizations most likely to follow the rules could leave the market, while the organizations least concerned with the rules remain.”

“The committee’s recommendations may determine whether the next chapter takes place inside the healthcare system—or even deeper inside the shadows.”

-

Key Points

⚡ The success of semaglutide, tirzepatide, and other injectable drugs has helped normalize self-injection and increased public interest in experimental peptides.

⚡ The “Ozempic halo” can cause consumers to assume that the word peptide automatically implies legitimacy, sophistication, and safety.

⚡ Approved peptide drugs and unapproved research peptides do not share the same level of clinical evidence, manufacturing oversight, or safety validation.

⚡ Research-use-only and “not for human consumption” labels often function as legal disclaimers while consumers use the products for self-administration.

⚡ Reddit, Discord, forums, and social media communities frequently provide reconstitution, dosing, stacking, and titration instructions outside clinical supervision.

⚡ Stacking several active peptides makes it difficult to determine which compound caused a benefit, side effect, laboratory change, or delayed complication.

⚡ Subjective dose adjustments based on appetite, sleep, recovery, or appearance create an informal and poorly monitored experimentation system.

⚡ A certificate of analysis may confirm identity or purity in a tested sample without establishing sterility, endotoxin burden, stability, potency, or quality of every vial sold.

⚡ Gray-market risks include mislabeling, contamination, non-sterility, inconsistent potency, degradation, infections, abscesses, and unidentified impurities.

⚡ Many peptide users do not disclose their use to physicians, creating a major gap in clinical surveillance and adverse-event reporting.

⚡ The July FDA meeting is not an approval hearing for BPC-157, MOTS-c, or the other reviewed peptides.

⚡ The committee will consider whether seven peptide-related bulk substances should be placed on the Section 503A Bulks List for potential patient-specific compounding.

⚡ On July 23, the committee is scheduled to review BPC-157, KPV, TB-500, and MOTS-c for specific nominated indications.

⚡ On July 24, it is scheduled to review DSIP, Semax, and Epitalon for selected neurological or sleep-related indications.

⚡ The FDA’s evaluation is limited to the nominated indications, formulations, and routes — not every benefit promoted online.

⚡ FDA staff preliminarily recommended against including all seven substances, citing insufficient human evidence, safety uncertainties, immunogenicity, impurities, and characterization concerns.

⚡ A favorable recommendation could create a more accountable pathway involving clinicians, prescriptions, licensed pharmacies, registered ingredient sources, testing, and medical records.

⚡ Inclusion on the 503A list would not make a peptide FDA-approved or legalize direct-to-consumer research-vial sales.

⚡ A negative decision could restrict legitimate compounding without eliminating demand, potentially pushing consumers further toward offshore or anonymous vendors.

⚡ A split decision may be the most realistic outcome because peptide substances differ significantly in structure, pharmacology, manufacturing complexity, evidence, and risk.

⚡ Advisory committee recommendations are non-binding, and any practical regulatory changes may take months through rulemaking and public-comment processes.

⚡ The core policy challenge is not simply access versus safety — it is determining where peptide use will occur and whether it can be tracked.

⚡ Regulation must acknowledge uncertainty without treating incomplete evidence as either proof of safety or proof of danger.

⚡ The peptide marketplace is evolving faster than the traditional drug-development system can respond.

⚡ The final outcome may determine whether peptide experimentation moves toward the healthcare system or deeper into the shadows.

-

Episode timeline

00:00–02:44 — Introduction to the gray-market peptide review and the upcoming FDA compounding discussion

02:45–04:00 — The normalization of the needle and the rise of the digital peptide exposure pathway

04:00–05:55 — Takeaway 1: The “Ozempic halo” and how approved peptide drugs lend perceived legitimacy to experimental compounds

05:56–07:08 — Takeaway 2: Research-use-only labeling, online communities, DIY reconstitution, and the legal-disclaimer loophole

07:09–08:29 — Takeaway 3: Peptide stacking, informal titration, and the surveillance gap created by self-experimentation

08:30–10:19 — Takeaway 4: The false security of third-party testing and the limits of certificates of analysis

10:21–11:43 — Takeaway 5: Non-disclosure, physician blind spots, retatrutide hype, and failures in adverse-event surveillance

11:44–13:23 — Review conclusion: distinguishing legitimate peptide medicine from opaque online supply chains

13:24–15:17 — The FDA’s July 23–24 peptide discussion and what the Section 503A Bulks List actually means

15:18–16:19 — The seven substances and the specific indications scheduled for committee review

16:20–17:39 — Why the FDA’s narrow indication-based framing could shape the outcome

17:40–20:15 — FDA staff’s preliminary opposition and the major evidence, safety, impurity, and characterization concerns

20:17–23:21 — Outcome 1: Favorable recommendation and the possible shift toward supervised pharmacy compounding

23:22–26:12 — Outcome 2: Rejection, reduced pharmacy access, gray-market displacement, and the evidence-financing gap

26:13–27:54 — Outcome 3: A split decision based on each peptide, formulation, indication, and route of administration

27:56–30:17 — What the meeting will not change: non-binding recommendations, delayed rulemaking, no FDA approval, and no legalization of research vending

30:18–32:19 — Potential effects on the gray market and the regulatory asymmetry between compliant and noncompliant sellers

32:21–33:51 — Questions the committee should ask about purity, aggregation, endotoxins, sterility, routes, registries, and evidence collection

33:52–35:00 — Why peptide innovation is moving faster than conventional regulation and drug development

35:01–37:11 — Closing argument: the decision is ultimately about what kind of peptide marketplace society chooses to create

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Dr. Mike walks through the basics of peptide structure, origin, function, receptor activity, and biological location, showing how peptides can be classified as natural or synthetic, linear or cyclic, hormonal or regulatory, GPCR-targeting or intracellular, and much more. The episode also explains why mitochondrial-derived peptides like MOTS-c, Humanin, and SHLPs are especially important for the future of mitochondrial medicine.

Ultimately, this episode presents peptides as the molecular language of life itself: tiny chains of amino acids that may help medicine shift from overriding biology to collaborating with it.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

“Individual amino acids are like letters. Peptides are words. Proteins are complete sentences or even entire chapters.”

“Peptides are the molecular language of life itself.”

“You cannot fully understand peptides without understanding mitochondria, and you cannot fully optimize mitochondria without understanding peptides.”

“Peptides influence every one of these (Six Pillars of Mitochondrial Wellness).”

“Peptides don’t replace mitochondria, of course, but they instruct mitochondria.”

“Aging itself, in one way, shape, or form, is really a communication problem.”

“One of the most exciting aspects of peptide science is the possibility of restoring healthier cellular communication.”

“Light and peptides are partners in cellular communication.”

-

Key Points

⚡ Peptides and mitochondria are not separate conversations; they are deeply connected through cellular communication, energy production, repair, and aging.

⚡ Mitochondria are environmental sensors that respond to hormones, nutrients, inflammation, stress, circadian signals, exercise, and gut-derived inputs.

⚡ Peptides are one of the primary languages through which cells communicate with mitochondria.

⚡ Peptides can influence all six pillars of mitochondrial wellness: ATP production, mitogenesis, mitophagy, dynamics, redox balance, and light-driven signaling.

⚡ Hormonal peptides such as insulin, GLP-1, GIP, and glucagon regulate nutrient entry into cells and influence oxidative phosphorylation.

⚡ Mitochondrial-derived peptides such as MOTS-c can support metabolic flexibility, insulin sensitivity, and cellular stress adaptation.

⚡ Some peptide pathways help activate PGC-1α, the master regulator of mitochondrial biogenesis.

⚡ Peptide signaling can support mitophagy by helping cells recycle damaged mitochondria before they become dysfunctional.

⚡ Peptides can indirectly regulate mitochondrial fusion and fission through cellular stress-response networks.

⚡ Glutathione is technically a peptide and plays a major role in redox balance and antioxidant defense.

⚡ Red and near-infrared light can influence peptide production, growth factors, inflammatory mediators, and cellular repair pathways.

⚡ Aging can be viewed not only as accumulated damage, but also as a breakdown in cellular communication.

⚡ Mitochondrial-derived peptides show that mitochondria do not merely receive peptide signals — they also produce their own.

⚡ Humanin, MOTS-c, and SHLPs are mitochondrial-derived peptides that influence metabolism, inflammation, insulin sensitivity, stress resistance, and longevity.

⚡ Peptides are short chains of amino acids linked together by peptide bonds.

⚡ Amino acids are like letters, peptides are like words, and proteins are like sentences or chapters.

⚡ Natural peptides are produced by the body and are often short-lived because the body rapidly breaks them down after they deliver their message.

⚡ Synthetic peptides may copy or modify natural peptides to improve stability, receptor specificity, half-life, and dosing convenience.

⚡ Peptides can be structurally classified as linear, cyclic, branched, or stapled.

⚡ Functionally, peptides can be classified as hormonal, regulatory, structural, signaling, or enzymatic.

⚡ Receptor-based classifications include GPCR-targeting peptides, tyrosine kinase receptor peptides, cytokine receptor peptides, ion channel-modulating peptides, and peptides that indirectly influence nuclear gene expression.

⚡ Biologically, peptides can act in endocrine, paracrine, autocrine, neurocrine, or intracellular ways.

⚡ Peptide science has exploded because of advances in synthesis, chemical engineering, AI drug discovery, receptor biology, delivery systems, and mitochondrial signaling research.

⚡ The future of medicine may be less about stronger drugs and more about smarter biological signals.

-

Episode timeline

00:00–01:08 — Introduction to the Peptides 101 episode and why The Energy Code is dedicating time to peptide basics

01:09–02:57 — Why peptides belong in a mitochondria-centered conversation and why peptides and mitochondria are part of the same biological story

02:58–04:44 — Mitochondria as environmental sensors and peptides as one of the body’s primary communication languages

04:46–06:28 — The six pillars of mitochondrial wellness and how peptides influence each one

06:29–07:18 — ATP production and mitogenesis: insulin, GLP-1, GIP, glucagon, MOTS-c, AMPK, and PGC-1α

07:19–08:24 — Mitophagy and mitochondrial dynamics: peptide signaling, quality control, fusion, fission, and mitochondrial network health

08:25–10:04 — Redox balance and light: glutathione as a peptide, ROS regulation, PBM signaling, and light-peptide communication

10:05–11:41 — Aging as a communication problem and peptides as central players in restoring cellular signaling

11:42–14:03 — Mitochondrial-derived peptides: Humanin, MOTS-c, SHLPs, and mitochondria as endocrine-like signaling organelles

14:05–16:28 — Medicine shifting from chemistry to communication and why mitochondria and peptides must be understood together

16:30–18:47 — Peptide architecture: amino acids, peptide bonds, oligopeptides, polypeptides, proteins, and the “language of biology” analogy

18:48–19:28 — Peptides as biological managers that tell cells what to do

19:29–22:52 — Classification by origin: natural/endogenous peptides versus synthetic peptides and modern peptide engineering

22:55–24:37 — Structural classification: linear, cyclic, branched, and stapled peptides

24:37–28:42 — Functional classification: hormonal, regulatory, structural, signaling, and enzymatic peptides

28:43–33:33 — Classification by receptor: GPCRs, tyrosine kinase receptors, cytokine receptors, ion channel-modulating peptides, and nuclear gene-expression effects

33:35–34:35 — Classification by biological location: endocrine, paracrine, autocrine, neurocrine, and intracellular peptides

34:36–36:09 — Why peptide science has exploded: synthesis, engineering, AI, delivery technologies, receptor biology, and mitochondrial research

36:11–37:24 — Closing thoughts: peptides as the molecular language of life and the future of smarter biological signaling

37:25–37:58 — Final message: upcoming peptide deep dives and mitochondrial medicine

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Drawing from a 2026 review in the International Journal of Molecular Sciences, the episode explains how peptides function as the body’s “biological software,” delivering precise molecular instructions that influence metabolism, tissue repair, inflammation, collagen production, cognitive function, mitochondrial health, and cellular resilience.

Dr. Mike breaks down major peptide categories, including GLP-1 agonists such as semaglutide, tirzepatide, and retatrutide; regenerative peptides such as BPC-157 and TB-500; growth hormone secretagogues; GHK-Cu; Semax, Selank, and DSIP; mitochondrial peptides such as MOTS-c, Humanin, SHLP-2, and SS-31; and topical aesthetic peptides including Argireline and Matrixyl 3000.

The episode also addresses the critical distinction between FDA-approved therapies and investigational compounds, emphasizing that peptide enthusiasm must be balanced with clinical evidence, product quality, regulatory awareness, and appropriate medical supervision. The emerging vision is not simply better drugs, but a future of personalized biological programming that works with the body’s own molecular language.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives

-

Key Quotes From Dr. Mike:

“Each peptide binds to highly specific receptors like a key fitting into a lock.”

“Peptide medicine represents a shift toward restoring biological communication before irreversible dysfunction occurs."

"Unlike traditional stimulants or sedatives, (Semax & Selank) aim to optimize normal brain function without producing significant sedation or overstimulation.”

“One of the newest frontiers in peptide science targets the very engines that power every cell — the mitochondria.”

“Enthusiasm should always be balanced with scientific rigor, product quality, and appropriate medical supervision.”

“The real revolution isn’t simply that we can create new peptides. It’s that we’re beginning to understand and speak the molecular language that has guided human biology for millions of years.”

-

Key Points

Key Points

⚡ Peptides are short chains of amino acids that primarily function as highly specific biological signaling molecules.

⚡ Peptides can be thought of as the body’s “biological software,” delivering instructions that regulate repair, metabolism, inflammation, collagen production, mitochondrial function, and cellular survival.

⚡ Unlike many conventional drugs, therapeutic peptides often mimic or amplify signaling pathways that already exist naturally within the body.

⚡ Peptide medicine represents a shift from suppressing symptoms toward restoring healthier biological communication.

⚡ GLP-1 receptor agonists such as Semaglutide transformed obesity treatment by improving satiety, glucose regulation, insulin sensitivity, and caloric control.

⚡ Tirzepatide activates both GLP-1 and GIP receptors, while Retatrutide adds glucagon-receptor activation as a triple agonist.

⚡ Early Retatrutide trials produced average weight reductions exceeding 22% after approximately one year.

⚡ Metabolic peptides may eventually influence cardiovascular disease, fatty liver disease, kidney health, inflammation, and neurodegenerative processes — not merely weight loss.

⚡ Regenerative peptides such as BPC-157 and TB-500 are being investigated for tissue repair, angiogenesis, wound healing, muscle recovery, and inflammation modulation.

⚡ Growth hormone secretagogues such as Tesamorelin, Ipamorelin, and CJC-1295 stimulate the body’s own pulsatile growth hormone release.

⚡ GHK-Cu may influence thousands of genes related to collagen production, wound repair, antioxidant defense, inflammation, and extracellular matrix remodeling.

⚡ Semax and Selank are being studied for cognition, stress resilience, neuroprotection, neurotransmitter balance, and anxiety-related effects.

⚡ DSIP remains under investigation for its potential role in sleep quality and recovery.

⚡ Mitochondrial-derived peptides such as MOTS-c, Humanin, and SHLP-2 help coordinate cellular responses to metabolic stress.

⚡ SS-31 targets cardiolipin in the inner mitochondrial membrane, helping stabilize mitochondrial structure and support electron transport and ATP production.

⚡ Topical peptides such as Argireline and Matrixyl 3000 demonstrate that peptide signaling can also support healthy skin aging.

⚡ Some peptides have extensive clinical evidence and FDA approval, while many popular biohacking peptides remain investigational.

⚡ Long-term safety, optimal dosing, purity, manufacturing quality, and regulatory status vary widely between peptide therapies.

⚡ Competitive athletes must consider WADA restrictions because many performance-related peptides are prohibited.

⚡ The future of peptide medicine may include tissue-specific therapies, mitochondrial-targeted compounds, and AI-designed peptide sequences.

⚡ Peptides are not miracle cures; they are powerful biological messengers that may help medicine work with human physiology rather than against it.

-

Episode timeline

00:00–01:10 — Introduction to the 2026 therapeutic-peptide review and the accelerating interest in peptide medicine

01:12–03:21 — Dr. Mike’s personal interest in peptides, their relationship to mitochondrial health, and upcoming peptide master classes

03:22–04:18 — The molecular messenger revolution: how peptides moved from background therapies to precision medicine and longevity science

04:20–05:47 — What peptides are and why they function like the body’s biological software

05:49–06:57 — Why peptide medicine may shift healthcare from symptom suppression toward healthier physiological programming

06:59–09:50 — Metabolic peptides: semaglutide, tirzepatide, retatrutide, triple agonism, weight loss, and whole-body metabolic signaling

09:52–11:58 — Regenerative medicine: BPC-157, TB-500, tissue repair, angiogenesis, inflammation, and growth hormone secretagogues

11:59–13:26 — GHK-Cu and the biology of aging: collagen, elastin, wound healing, gene expression, and regenerative potential

13:28–15:12 — Brain health and cognitive performance: Semax, Selank, DSIP, BDNF, GABA signaling, and neuroprotection

15:15–16:59 — The mitochondrial revolution: MOTS-c, Humanin, SHLP peptides, SS-31, cardiolipin, and cellular energy restoration

17:00–18:01 — Peptides in aesthetic medicine: Argireline, Matrixyl 3000, wrinkle reduction, collagen, and skin elasticity

18:03–19:20 — The safety question: FDA approval, investigational use, long-term evidence, product quality, supervision, and anti-doping rules

19:22–20:31 — The future of precision medicine: tissue-specific peptides, mitochondrial targeting, and AI-designed sequences

20:32–22:34 — Final synthesis: peptides as powerful molecular messengers — not miracle cures — and their role in the future of The Energy Code

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Along the way, he breaks down why chronic fatigue and brain fog often evade standard labs, walks through the origin story and chemistry of shilajit, highlights ATP and endurance data, explains PQQ’s unique role in building new “cellular engines,” and tells the bizarre history of methylene blue — from textile dye to essential emergency medicine — before tying it all together as structure + supply + backup mechanics for cellular energy. He closes with launch details, the first-week discount code, and where to find the full resource library on the BioLight product page.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Fullerenes as Anti-Aging Antioxidants

-

Key Quotes From Dr. Mike:

Regarding BioShilajit: "A mountain resin, a bacterium, and a clothing dye… sounds like quite the trio.”

“Shilajit roughly translates to: the conqueror of mountains and destroyer of weakness.”

“Shilajit contains over 85 distinct trace minerals — and the key word is bioavailable.”

“Shilajit is the pharmacological opposite of a stimulant — it doesn’t tape over the check-engine light; it helps the cell produce more of its own ATP.”

“A microscopic picomolar concentration of PQQ can execute thousands — sometimes tens of thousands — of redox cycles without breaking down.”

“PQQ triggers this exact same genetic alarm bell (PGC-1α -> mitogenesis) — but without the ten-mile run.”

“Inside damaged mitochondria, methylene blue’s mechanism is bypassing the blockade (blockages in the ETC).”

-

Key Points

• Two BioLight events + one roadmap: Beyond Conference (Austin, May 27–29), Return to Nature (Franklin, June 11–12), and a tentative A4M plan (December).
• Core thesis: chronic fatigue/brain fog often reflects micro-level mitochondrial “power grid” failure, not a single broken marker on standard labs.
• BioShilajit = “unlikely trio”: shilajit + PQQ + methylene blue designed as a closed-loop energy system.
• Shilajit basics: paleo-humus resin rich in fulvic/humic acids, DBP-like compounds, and ionic trace minerals for high absorption.
• ATP angle: shilajit framed as ATP preservation + ETC enzyme protection under stress (mouse forced-swim model described).
• Stimulant vs metabolic: shilajit positioned as the opposite of “masking fatigue” (caffeine analogy).
• PQQ: framed as a catalytic redox molecule tied to mitochondrial biogenesis via PGC-1α / CREB signaling.
• Methylene blue: framed as a low-dose electron cycler that can bypass bottlenecks in the ETC, especially relevant to brain energy.
• Safety/precision: strong emphasis on dose hormesis + USP pharmaceutical grade only (avoid aquarium/industrial impurities).

-

Episode timeline

00:01:07–00:03:37 — Beyond Conference (Austin, May 27–29): booth location + product teases 00:03:56–00:05:58 — Speaking topics + Return to Nature (Franklin, June 11–12) + vibe contrast 00:06:13–00:06:51 — Tentative A4M (December) + lead-in to minerals line 00:06:51–00:07:59 — Minerals stack → pivot to BioShilajit announcement 00:07:59–00:10:23 — Why “binary medicine” fails fatigue/brain fog; “wrong level” diagnosis 00:10:24–00:12:34 — The “unlikely trio” frame: mountain resin + bacterial cofactor + blue dye 00:12:43–00:16:40 — Shilajit origin stories + sensory reality + what it is (paleo-humus) 00:20:14–00:22:17 — Molecular payload: fulvic/humic acids + trace minerals + safety/purity note 00:22:26–00:29:32 — Evidence + mechanisms: ATP/fatigue model + “not a stimulant” analogy 00:29:32–00:34:02 — Hormones + cognition: testosterone study overview + tau aggregation discussion 00:34:02–00:39:10 — Shilajit “matchmaker” model: fulvic delivery + DBP-style mitochondrial cleanup 00:39:10–00:48:53 — PQQ deep dive: discovery, “vitamin-like” role, redox cycling, biogenesis signaling 00:49:24–01:05:24 — Methylene blue: history → ETC bypass model → brain relevance → dose/sourcing warnings 01:05:24–01:12:25 — Closed-loop synergy: build engines (PQQ) + supply/protect (shilajit) + failsafe (MB) 01:12:25–01:15:48 — Launch details + discount code + deadline (through May 7) 01:15:54–01:18:41 — Product page “mini-library” + shoutout + closing

-

For the next week, save 20% on your order of BioShilajit!

And for the next week ONLY, you can combine this 20% discount with the Subscribe and Save 10% discount option* (choose on the product page when adding to cart).

This limited-time offer provides you with a 30% discount on BioShilajit and you will retain this exclusive discount of the lifetime of your subscription.

Discount code: BIOSHILAJIT20

Expires on 5/7, midnight PST

*must choose "Single" quantity option and then increase to desired amount

Shop BioShilajit!

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Drawing from two reviews on mitochondrial chronobiology, the episode examines how mitochondrial fusion, fission, energy production, mitophagy, NAD metabolism, and oxidative stress follow rhythmic patterns throughout the day. It also breaks down the two-way conversation between the nuclear clock and the mitochondria, including how metabolic signals such as NAD, ATP, AMP, and acetyl-CoA can reshape clock-gene activity.

The discussion moves even deeper into evidence that biological rhythms can persist without a nucleus, suggesting that mitochondria may retain elements of an ancient metabolic clock inherited from their bacterial ancestors. Ultimately, the episode reveals why light, food timing, exercise, sleep, and metabolism must remain synchronized to preserve mitochondrial efficiency, metabolic health, resilience, and longevity.

(Educational content only, not medical advice.)

-

Articles Discussed in Episode:

The Circadian nature of Mitochondrial Biology 

Circadian coordination: understanding interplay between circadian clock and mitochondria 

-

Key Quotes From Dr. Mike:

“What if mitochondria aren’t just responding to the circadian clock? What if they’re helping actually keep it?”

“Your circadian clock isn’t simply measuring time. It’s also measuring energy.”

“Our mitochondria aren’t just passive recipients of that information. They’re active participants in deciding what time it actually is.”

“When the nucleus and mitochondria are in sync, energy production peaks exactly when you need it.”

“The mitochondria beat more to a metabolic clock... Consistent eating patterns provide the metabolic cues necessary to keep mitochondrial activity on beat.”

“Mitochondria are rhythmic shape-shifters... Failing to maintain this shape-shifting rhythm (i.e. fusion & fission) is a hallmark of cellular aging and metabolic decline.”

-

Key Points

⚡ Mitochondria are not simply ATP-producing organelles; they are signaling hubs, redox regulators, environmental sensors, and cellular decision-makers.

⚡ The relationship between the circadian clock and mitochondria is a two-way conversation rather than a one-directional command from the nucleus.

⚡ Clock genes influence mitochondrial biogenesis, mitophagy, fusion, fission, oxidative phosphorylation, NAD metabolism, and reactive oxygen species production.

⚡ Mitochondria communicate back to the nucleus through metabolites such as NAD, ATP, AMP, acetyl-CoA, and cellular redox status.

⚡ The circadian clock may be measuring both time and energy.

⚡ Mitochondrial fusion and fission follow rhythmic patterns that help cells adapt their physical structure to changing energy demands.

⚡ Fusion creates elongated mitochondrial networks optimized for efficient oxidative phosphorylation and energy production.

⚡ Fission separates mitochondrial networks into smaller units, supporting quality control and the removal of damaged components.

⚡ Loss of the normal fusion-fission rhythm is associated with cellular aging, oxidative stress, and metabolic decline.

⚡ SIRT1 acts as a metabolic sensor linking NAD availability to clock proteins such as PER2.

⚡ Biological rhythms can exist without nuclear DNA, as demonstrated by circadian peroxiredoxin oxidation in enucleated red blood cells.

⚡ Mitochondria also exhibit approximately 12-hour ultradian rhythms that appear to respond more strongly to metabolic and cellular stress cues than to light.

⚡ These independent rhythms support the theory that mitochondria retained ancient biological clocks from their bacterial ancestors.

⚡ Disrupting clock genes such as BMAL1, PER1, or PER2 physically damages mitochondrial structure and impairs cellular respiration.

⚡ Peripheral clocks in organs such as the liver, heart, and skeletal muscle respond strongly to feeding and fasting schedules.

⚡ Consistent meal timing can help synchronize mitochondrial enzyme activity, protein acetylation, NAD metabolism, and energy production.

⚡ Circadian disruption and mitochondrial dysfunction may reinforce one another, contributing to metabolic disease, neurodegeneration, accelerated aging, and reduced longevity.

⚡ Circadian health is influenced by more than light—it also depends on the timing of meals, exercise, sleep, temperature, and metabolic activity.

-

Episode timeline

00:00–00:25 — The Energy Code Deep Dives introduction

00:25–01:34 — Mitochondria as energy producers, signaling hubs, redox regulators, environmental sensors, and producers of ATP and EZ water

01:35–02:52 — The central question: Do mitochondria merely follow the circadian clock, or do they help keep it?

02:53–04:40 — Overview of mitochondrial rhythms, nuclear-mitochondrial communication, ancient biological clocks, and the two featured reviews

04:42–06:23 — Circadian disruption as a cellular power failure; the nucleus and mitochondria as a synchronized energy orchestra

06:24–07:30 — Takeaway 1: Mitochondria as rhythmic shape-shifters through fusion and fission

07:31–08:54 — Takeaway 2: Retrograde signaling and the two-way conversation between mitochondria and the nucleus

08:56–10:44 — Takeaway 3: Rhythms without a nucleus, red blood cells, 12-hour mitochondrial cycles, and the endosymbiotic theory

10:44–11:44 — Takeaway 4: The physical consequences of clock-gene disruption and mitochondrial structural damage

11:45–12:56 — Takeaway 5: Metabolism as a master synchronizer through feeding, fasting, SIRT3, NAMPT, and NAD biology

12:58–13:37 — Why the interaction between time and energy may be foundational to longevity

13:39–17:13 — Conclusions from the 2024 review: mitochondrial clocks, bacterial ancestry, disease, aging, and systemic circadian coordination

17:14–19:46 — Final analysis: mitochondrial timing appears especially responsive to metabolism and meal timing, not light alone

19:48–20:03 — Closing message and podcast outro

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Drawing from five influential research papers, Dr. Mike explains how the eyes act as circadian sensors, why the timing, spectrum, and intensity of light all matter, and how modern life creates a damaging mismatch: too little bright, full-spectrum light during the day and too much blue-rich artificial light at night. He also breaks down why morning sunlight may be one of the most powerful free wellness interventions available — and why nighttime success begins shortly after waking.

The episode concludes with practical strategies for designing a more circadian-friendly environment and introduces the BioLight Ember, a portable, rechargeable light with adjustable brightness and three evening-friendly modes: amber, red, and amber/red combined. The central message is simple: you cannot out-supplement or out-biohack a poor circadian rhythm, but you can begin correcting it by sending your biology the right light signals at the right time.

(Educational content only, not medical advice.)

-

Articles Discussed in Episode:

Effects of light on human circadian rhythms, sleep and mood

Circadian Rhythm, Lifestyle and Health: A Narrative Review

Systematic review of light exposure impact on human circadian rhythm

Role of Circadian Health in Cardiometabolic Health and Disease Risk: A Scientific Statement From the American Heart Association

The role of sunlight in sleep regulation: analysis of morning, evening and late exposure

-

Key Quotes From Dr. Mike:

“You can’t out-supplement or out-biohack a poor circadian rhythm.”

“The body doesn’t know what time it is. It only knows what signals it receives... Light is the strongest timing signal humans possess. Everything else is secondary.”

“If there was one circadian intervention that consistently outperforms nearly every supplement, it’s morning sunlight.”

“The goal isn’t to eliminate light altogether (at night). The goal is to become intentional about which light we’re exposing ourselves to and at what time.”

“Health isn’t always about adding another piece of technology or nutraceutical. Sometimes it’s simply about changing the environment your biology evolved to expect.”

-

Key Points

⚡ Circadian rhythm is not simply about sleep; it influences metabolism, hormones, cardiovascular function, inflammation, cognition, mitochondrial health, and longevity.

⚡ Morning sunlight is one of the most powerful free habits for setting the body’s master clock and improving both daytime alertness and nighttime sleep.

⚡ The eyes contain specialized circadian sensors called intrinsically photosensitive retinal ganglion cells, or ipRGCs, that help determine whether the body interprets its environment as day or night.

⚡ The same light can produce opposite effects depending on when it is viewed.

⚡ Morning light advances the circadian clock, increases alertness, supports a healthy cortisol rise, and promotes earlier melatonin onset that evening.

⚡ Bright and blue-rich light at night delays the circadian clock, suppresses melatonin, increases alertness, and reduces sleep quality.

⚡ The body does not know what clock time it is — it responds to environmental signals, with light acting as the strongest timing cue.

⚡ Virtually every major organ and tissue contains its own molecular clock, including the liver, pancreas, gut, immune system, and mitochondria.

⚡ Shift work, late-night eating, artificial lighting, social jet lag, inconsistent schedules, and sleep deprivation all contribute to circadian mismatch.

⚡ Modern indoor lighting is often too dim during the day and too bright at night.

⚡ Typical indoor environments provide roughly 100–500 lux, while outdoor daylight can reach approximately 10,000–100,000 lux.

⚡ Circadian responses depend on both the brightness and color spectrum of light — not merely one or the other.

⚡ Blue-rich light disproportionately affects melanopsin signaling, cortisol, alertness, melatonin suppression, and circadian phase shifting.

⚡ Circadian disruption is linked with impaired insulin sensitivity, poor glucose control, cardiovascular dysfunction, inflammation, depression, cognitive decline, and increased disease risk.

⚡ Nighttime success begins in the morning: earlier outdoor sunlight exposure is associated with better circadian alignment, earlier melatonin onset, and improved sleep quality.

⚡ The goal is not to eliminate evening light entirely, but to become more intentional about its timing, intensity, and wavelength.

⚡ The BioLight Ember is portable and rechargeable, offers amber, red, and amber/red combination modes, and allows complete control over brightness.

⚡ The Ember is not a sedative or replacement for healthy sleep habits; it is designed to remove one major environmental source of circadian disruption.

⚡ Consistency, not perfection, is what ultimately moves the needle for circadian rhythm.

-

Episode timeline

00:00–00:25 — The Energy Code introduction

00:25–03:45 — Why circadian rhythm is foundational; morning sunlight, evening lighting, melatonin, and the importance of red light at night

03:46–05:14 — Introduction to five major circadian-health papers and the upcoming BioLight product announcement

05:15–09:55 — Paper 1: Light as a biological signal; ipRGCs, sleep, mood, hormones, alertness, and why timing changes the effect of light

09:57–10:25 — Morning sunlight and the evening environment as the two foundational circadian anchors

10:28–15:11 — Paper 2: Circadian rhythm as a whole-body health system; organ clocks, metabolic health, shift work, late eating, social jet lag, and artificial light

15:12–17:53 — Paper 3: Real-world artificial-light exposure; why indoor daytime lighting is biologically weak compared with outdoor sunlight

17:55–21:43 — Why nighttime lighting is often too bright; intensity versus spectrum and the foundation of modern circadian-lighting products

21:44–23:49 — Paper 4: The American Heart Association recognizes circadian disruption as a cardiometabolic risk factor

23:51–26:00 — Paper 5: Morning sunlight exposure, melatonin timing, sleep regulation, and why nighttime success begins in the morning

26:00–27:52 — The overarching lesson: modern health problems may partly reflect inaccurate environmental light signals

27:53–28:52 — Practical framing: modern life is not going away, so the goal is intentional light exposure rather than complete darkness

28:53–31:05 — Introduction to the BioLight Ember and why portability was central to its design

31:06–33:28 — Everyday use cases: reading, bathrooms, travel, hotel rooms, nightstands, and adjustable brightness

33:29–36:23 — The Ember’s three light settings: amber, red, and amber/red combination mode

36:24–39:10 — What the Ember is—and is not; reducing environmental stress rather than acting as a magic sleep device

39:11–42:31 — Practical circadian takeaways, Ember quantity options, potential sleep and HRV benefits, and why consistency matters

42:32–43:47 — Closing message: morning sunlight, evening-light hygiene, and mitochondrial medicine

-

Introducing Ember.

Meet BioLight’s newest addition to your evening wellness routine.

Ember is a rechargeable, portable circadian light designed to help create a healthier nighttime environment with three blue-free light modes: Amber, Red, and Amber + Red. With adjustable brightness and USB-C charging, it’s perfect for bedrooms, bathrooms, reading, travel, or anywhere harsh lighting gets in the way of your evening routine.

Because better sleep doesn’t start when your head hits the pillow—it starts with the light you’re surrounded by.

Check out Ember!

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

The findings reveal a striking disconnect between feeling recovered and actually being physiologically recovered. Compression boots and shockwave therapy earned high satisfaction scores, but failed to outperform passive rest for muscle damage or power recovery. Photobiomodulation combined with a static magnetic field was the only intervention to preserve vertical-jump performance, reduce biochemical markers of muscle damage, and strengthen endogenous antioxidant defenses over the following 24 to 48 hours.

The episode explores the study’s specific light protocol, the “invisible recovery window” immediately after intense exercise, and why mitochondrial and oxidative-stress recovery may matter more than how your legs feel in the moment.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

A randomised crossover trial comparing photobiomodulation therapy with other recovery strategies in CrossFit athletes

-

Key Quotes From Dr. Mike:

“The most striking finding was the massive disconnect between an athlete’s subjective feelings and their objective physiology.”

“Shock waves and compression boots might make post-WOD soreness more bearable, but they simply don’t help you regain peak power any faster.”

“Photobiomodulation combined with a static magnetic field was the only intervention that significantly outperformed passive rest.”

“To understand why photobiomodulation won, you have to look at the microscopic war zone inside your muscle cells... High-intensity CrossFit workouts trigger a massive spike in reactive oxygen species... Photobiomodulation acts as an internal antioxidant booster.”

“Pneumatic boots are mostly for show... The boots provided no statistically significant benefit over passive recovery for muscle damage or power output.”

“If you want to return to the barbell with maximum power, photobiomodulation is currently the only technology in this trial with scientific receipts to back it up.”

-

Key Points

⚡ The study compared photobiomodulation with a static magnetic field, pneumatic compression boots, shockwave therapy, and passive recovery in CrossFit athletes.

⚡ Compression boots and shockwave therapy received 83% satisfaction ratings, showing that athletes enjoyed the treatments.

⚡ Despite those high satisfaction scores, neither treatment significantly improved vertical-jump recovery or muscle-damage markers compared with passive rest.

⚡ The study highlights a major disconnect between subjective recovery and objective physiological recovery.

⚡ Photobiomodulation combined with a static magnetic field was the only intervention to significantly outperform passive recovery across functional and biochemical outcomes.

⚡ Athletes receiving PBM retained more vertical-jump power at the 24- and 48-hour marks.

⚡ PBM also reduced lactate dehydrogenase, a biomarker associated with muscle-cell membrane damage.

⚡ The study used a 32-minute protocol across eight treatment sites on each lower limb, targeting the quadriceps, hamstrings, and calves.

⚡ The device combined 905-nanometer super-pulsed lasers with 850-nanometer and 633-nanometer LEDs.

⚡ None of the recovery methods restored jump performance at the one-hour mark, including PBM.

⚡ PBM nevertheless increased antioxidant activity within 60 minutes, suggesting internal repair had begun before athletes felt or performed better.

⚡ PBM lowered markers of lipid and protein oxidation, including TBARS and carbonylated proteins.

⚡ It was also the only intervention to maintain or increase superoxide dismutase and catalase activity.

⚡ Compression boots may provide a strong sensory experience, but this trial did not show meaningful metabolic or performance recovery.

⚡ The central lesson: choose recovery tools based on how they affect performance 24 to 48 hours later—not merely how they feel immediately after training.

-

Episode timeline

00:00–01:49 — Introduction to the CrossFit recovery trial and the “science of the slay”

01:51–02:55 — Why a CrossFit WOD creates extreme mechanical, metabolic, and oxidative stress

02:57–04:30 — The satisfaction paradox: why compression boots and shockwave therapy feel effective without improving objective recovery

04:32–06:27 — PBM emerges as the leading intervention; improvements in jump performance and muscle-damage biomarkers

05:30–06:27 — The winning protocol: 32 minutes, eight sites per leg, and a combination of red/NIR LEDs and super-pulsed lasers

06:29–07:50 — The invisible recovery window: why no device restored performance one hour after the WOD

07:52–09:42 — The oxidative-stress battle: PBM’s effects on TBARS, carbonylated proteins, superoxide dismutase, and catalase

09:43–10:34 — Why pneumatic compression boots failed to outperform passive rest

10:35–11:24 — Feeling recovered versus being physiologically recovered

11:25–13:09 — The authors’ conclusion and the practical question every athlete should ask about recovery technology

13:11–13:27 — Closing message and podcast outro

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Dr. Mike breaks down how light interacts with mitochondrial cytochrome c oxidase, improves electron flow and ATP production, and may restore bioenergetics in two of the body’s most energy-demanding tissues: the brain and retina. The episode also examines the LIGHTSITE clinical trials, repeated low-level red-light therapy for myopia, transcranial PBM for sleep, extra-pineal melatonin production, and why proper wavelength, irradiance, and dosage remain essential.

The emerging message is that red light may be far more than a tool for skin, pain, and muscle recovery. It may represent an investigational strategy for restoring cellular energy in the tissues responsible for how clearly we see and how deeply we sleep.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Near-Infrared and Red-Light Photobiomodulation for Ocular Aging and Diseases: A Narrative Review

Photobiomodulation and sleep quality: systematic review and meta-analysis

-

Key Quotes From Dr. Mike:

“Many of the conditions we associate with aging and declining function may ultimately be manifestations of an underlying energy problem.”

“We are witnessing a bioenergetic tipping point where mitochondrial decay dictates the pace of systemic aging.”

“The human eye is an ideal target for PBM due to its optical accessibility and the immense energy demands of the retina.”

“Brief exposures to red light can slow the progression of myopia in children.”

“PBM may help restore homeostatic sleep pressure — the biological need to sleep... Red and near-infrared wavelengths have the capability of improving our systemic melatonin production.”

“The gastrointestinal tract is likely the largest source of melatonin in the body.”

“If mitochondria contribute to melatonin production, all of a sudden full-body red light therapy becomes imperative for normalizing circadian rhythm.”

-

Key Points

⚡ Two new reviews examine photobiomodulation for ocular aging and disease and for sleep quality.

⚡ The brain and retina are among the body’s most energy-demanding tissues, making them especially vulnerable to mitochondrial decline.

⚡ Red and near-infrared light interact with cytochrome c oxidase, helping displace inhibitory nitric oxide, restore oxygen utilization, and increase ATP production.

⚡ PBM follows a Goldilocks dose response: too little may do nothing, while excessive light can become inhibitory or pro-oxidative.

⚡ The LIGHTSITE clinical trials reported modest but statistically significant visual-acuity gains of roughly four to five ETDRS letters in patients with dry age-related macular degeneration.

⚡ Ocular PBM may also reduce drusen burden and potentially slow geographic atrophy, although further clinical confirmation is needed.

⚡ Repeated low-level red-light therapy is being studied as a way to slow the abnormal eyeball elongation responsible for childhood myopia.

⚡ Ocular protocols differ by goal: age-related macular degeneration often uses multiple red, amber, and near-infrared wavelengths, while myopia protocols typically use red light alone.

⚡ Wavelength determines penetration depth; device strength primarily determines how quickly a therapeutic dose is delivered.

⚡ High-powered panels should not be used close to the eyes without carefully adjusting distance, exposure time, and irradiance.

⚡ Transcranial PBM may support sleep by influencing adenosine signaling, cerebral metabolism, astrocytes, and prefrontal and thalamocortical networks.

⚡ Current sleep findings are statistically promising, but may not yet represent clinically meaningful improvements.

⚡ Red and near-infrared light may also support sleep indirectly by improving mitochondrial function and extra-pineal melatonin synthesis.

⚡ Melatonin is produced throughout the body — including the retina, gastrointestinal tract, skin, immune cells, cardiovascular tissues, and mitochondria — not only in the pineal gland.

⚡ PBM should currently be viewed as a promising adjunctive and investigational tool, not a replacement for established medical care.

-

Episode timeline

00:00–03:17 — Return to the podcast’s red-light roots; introduction to two new reviews on sleep and ocular PBM

03:18–05:54 — Why the retina and brain are ideal — and very different — targets for red and near-infrared light

05:55–06:44 — Research context and Francisco Gonzalez-Lima’s involvement in both papers

06:45–08:48 — The invisible cellular engine: mitochondrial decline, aging, and PBM as a nonthermal bioenergetic intervention

08:49–10:24 — The mitochondrial master switch: cytochrome c oxidase, nitric oxide displacement, oxygen utilization, ATP, and the biphasic dose response

10:25–13:28 — Saving sight: the LIGHTSITE clinical program, ETDRS letter gains, drusen reduction, and dry macular degeneration

13:29–16:25 — The myopia paradox: how low-level red light may slow abnormal eye elongation in children

16:27–17:56 — Comparing ocular protocols: multi-wavelength PBM for macular degeneration versus red-only treatment for myopia

17:58–21:20 — Practical eye-treatment considerations: irradiance, distance, exposure time, low-powered devices, and screen-light balancing

21:21–22:46 — The prefrontal “off switch”: transcranial PBM, adenosine signaling, brain-network efficiency, and sleep quality

22:47–23:21 — Research limitations: statistical significance versus clinically meaningful improvement

23:22–26:49 — Extra-pineal melatonin: the retina, gut, skin, immune cells, reproductive tissues, and mitochondria

26:50–27:38 — How consistent PBM, sunlight, evening darkness, and circadian lighting may work together to support sleep

27:40–29:35 — Final synthesis: PBM as an investigational adjunct, future applications in spaceflight, and illuminated healthcare

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Dr. Mike covers urolithin A and B, shilajit, mitochondrial peptides, nano gold, taurine, molecular hydrogen, deuterium depletion, hyperbaric oxygen therapy, circadian light, indoor lighting, and grounding. The episode then brings everything together into a practical “Energy Code Blueprint,” outlining a daily and weekly framework for the true mitochondriac: sunlight, grounding, mitohormesis, red light therapy, methylene blue, selective antioxidants, mitochondrial peptides, and foundational compounds that support cellular energy, resilience, and longevity.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

“Urolithin A is simply one of the most effective, efficient, efficacious ways to activate the mitophagy switch.”

“SS-31 arguably is the top peptide I would recommend for overall mitochondrial function.”

“MOTS-c… is essentially exercise in a molecule... Humanin… is known as a cognitive or neuroprotector in terms of a peptide... SHLP-2… is the cellular survival signal peptide... (SS-31, MOTS-c, Humanin & SHLP-2) are the peptides I would look at from a mitochondriac perspective.”

“Nano gold itself doesn’t create energy; it multiplies & amplifies the light that does.”

“Molecular hydrogen penetrates every cellular compartment, including the mitochondria.”

“Deuterium depletion is one of the most powerful overlooked levers to upgrade mitochondrial function.”

“Morning sun is a must.”

-

Key Points

⚡ This episode completes the three-part breakdown of The Energy Code Blueprint: Longevity Starts in the Mitochondria.

⚡ Part 3 focuses on the practical applications: what people can actually do to support the six pillars of mitochondrial function.

⚡ Urolithin A is framed as one of the most effective ways to activate mitophagy, helping clear damaged mitochondria and restore mitochondrial quality control.

⚡ Urolithin B is positioned as an anabolic mitokine that may support muscle retention, protein synthesis, joint health, and metabolic resilience.

⚡ Shilajit is described as a foundational mitochondrial compound because of its fulvic acid, trace minerals, CoQ10 support, and ability to improve ATP and EZ water production.

⚡ The four core mitochondrial peptides highlighted are SS-31, MOTS-c, SHLP-2, and Humanin, with honorable mentions for Epitalon, GHK-Cu, and Pinealon.

⚡ Nano gold is presented as a light-amplifying mitochondrial tool that may enhance the effects of red and near-infrared light via surface plasmon resonance.

⚡ Taurine is described as a mitochondrial game changer due to its effects on oxidative stress, ETC efficiency, mitophagy, inflammation, brain health, heart health, and calcium regulation.

⚡ Molecular hydrogen is framed as a selective antioxidant that neutralizes the most harmful radicals while preserving beneficial redox signaling.

⚡ Deuterium depletion is explained as an overlooked lever for improving ATP synthase efficiency, electron flow, mitochondrial respiration, and cellular energy.

⚡ Hyperbaric oxygen therapy is discussed as a mitochondrial oxygenation strategy that may improve ATP production, mitogenesis, cellular repair, and the nitric oxide “golden ratio.”

⚡ Circadian light hygiene—morning sun, evening darkness, amber/red lighting, and blue-light blocking—is positioned as a foundational mitochondrial signal.

⚡ Grounding is described as a free electron-transfer strategy that supports redox potential, inflammation control, blood flow, sleep, and mitochondrial function.

⚡ The final Energy Code Blueprint begins with the free foundations: sunlight, circadian rhythm, grounding, and mitohormesis.

⚡ The “multiplier effect” is the main theme: when foundational signals align, every other mitochondrial tool works better.

-

Episode timeline

0:00–2:10 — Part 3 intro and recap of Parts 1–2: bioenergetics, six pillars, and earlier applications 2:11–9:03 — Urolithin A: mitophagy activation, mitochondrial quality control, muscle performance, and long-term cellular renewal 9:04–13:51 — Urolithin B: anabolic signaling, muscle retention, joint protection, osteoarthritis support, inflammation, and metabolic flexibility 13:52–18:18 — Shilajit: fulvic acid, trace minerals, CoQ10 recycling, ATP/EZ water production, brain support, and mineral replenishment 18:21–27:43 — Mitochondrial peptides: SS-31, MOTS-c, SHLP-2, Humanin, plus Epitalon, GHK-Cu, and Pinealon as honorable mentions 27:43–32:52 — Nano gold: light amplification, surface plasmon resonance, red/NIR synergy, and mitochondrial activation 32:54–38:06 — Taurine: antioxidant defense, ETC support, mitophagy, inflammation control, neurotransmitters, metabolic health, and synergy with methylene blue 38:09–42:16 — Molecular hydrogen: selective antioxidant activity, delivery methods, systemic vs gut benefits, and daily use potential 42:16–49:37 — Deuterium depletion: hydrogen vs deuterium, ATP synthase function, light water, mitochondrial efficiency, and anti-aging implications 49:37–54:07 — Hyperbaric oxygen therapy: oxygen delivery, mitochondrial energy production, wound healing, immune support, and the nitric oxide “golden ratio” 54:08–56:52 — Circadian light and indoor lighting: morning sun, evening darkness, blue light, amber/red bulbs, and sleep signaling 56:54–59:47 — Grounding/earthing: electron transfer, redox potential, inflammation, blood viscosity, melatonin, cortisol rhythm, and wound healing 59:48–1:00:13 — Recap of all mitochondrial applications covered across the series 1:00:14–1:03:40 — The Energy Code Blueprint: foundations, multiplier effect, and matching applications to the six pillars 1:03:42–1:07:31 — Daily checklist example: morning sunlight/grounding, urolithins, shilajit, blue spirulina, methylene blue, red light, SS-31, PQQ, C60, hydrogen, and lighting upgrades 1:07:33–1:08:54 — Hard reboot strategy for beginners and closing message: “The mitochondrial revolution is not the future, it’s now.”

-

Introducing BioLight Labs!

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

This episode breaks down a 2023 systematic review from Biology titled “Humanin and Its Pathophysiological Roles in Aging”, covering Humanin’s unusual mitochondrial origin, its role in neuroprotection, mitohormesis, chaperone-mediated autophagy, metabolic health, cardiovascular function, inflammation, and lifespan research. Dr. Mike also explains why Humanin may deserve a place alongside SS-31 and MOTS-c as one of the top mitochondrial peptides for anyone interested in mitochondrial wellness, resilience, and longevity.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Humanin and Its Pathophysiological Roles in Aging: A Systematic Review

-

Key Quotes From Dr. Mike:

“Humanin was originally isolated from surviving neurons in the brains of patients with Alzheimer’s disease"

"It was named 'Humanin' to reflect its potential role in preserving human health and survival."

 “Humanin appears to function as one of the body’s natural cellular survival signals... acting as a molecular shield and mitokine."

“Humanin restores the communication link that tells the cleanup crew exactly where the toxic debris is hiding.”

“By addressing the mitochondrial origin of this inflammation — the leaky battery problem — Humanin hits multiple diseases simultaneously.”

"These are the top three peptides if you’re a mitochondriac: SS-31, MOTS-c, and now you can see why the third is Humanin.”

-

Key Points

⚡ Humanin is a small mitochondrial-derived peptide first discovered in 2001 during research into Alzheimer’s disease-related neuronal protection.

⚡ It was originally isolated from surviving neurons in the brains of Alzheimer’s patients, which helped shape its identity as a cellular survival peptide.

⚡ Humanin is encoded within the mitochondrial genome, specifically inside the 16S ribosomal RNA gene, giving mitochondria their own “voice” beyond ATP production.

⚡ It exists in two forms: a 21-amino-acid version when translated in mitochondria and a 24-amino-acid version when translated in the cytoplasm.

⚡ Humanin is highly conserved across species, suggesting it may play a fundamental role in multicellular survival and stress resistance.

⚡ It may protect against Alzheimer’s-related toxicity by interfering with amyloid beta toxicity and blocking pro-apoptotic pathways like Bax activation.

⚡ Humanin functions as a mitokine, released during periods of mitochondrial stress to coordinate resilience across cells and tissues.

⚡ Humanin levels generally decline with age, although some very old individuals may show compensatory spikes as a last-ditch mitohormetic stress response.

⚡ It supports chaperone-mediated autophagy, helping the cell’s “precision cleanup crew” remove damaged or oxidized proteins.

⚡ Humanin has broad systemic effects, including potential benefits for brain health, cardiovascular aging, insulin sensitivity, visceral fat, lean mass, inflammation, stem cell survival, and reproductive health.

⚡ Animal models suggest even modest increases in circulating Humanin may provide protection against toxic insults and inflammatory markers.

⚡ A synthetic analog called HNG / Humanin S14G may be up to 1,000 times more potent than naturally occurring Humanin in certain models.

⚡ Dr. Mike frames Humanin as the third part of a mitochondrial peptide “big three” alongside SS-31 and MOTS-c.

-

Episode timeline

0:00–0:40 — Introduction to Humanin as another mitochondrial-derived peptide; article title and source 0:40–1:47 — Historical overview: Humanin discovery in 2001, Alzheimer’s research, and the birth of mitochondrial-derived peptide science 1:47–3:23 — Humanin’s potential benefits: mitochondrial function, oxidative stress protection, metabolism, brain health, inflammation, stem cells, fertility, and cellular resilience 3:23–4:52 — Big-picture framing: Humanin as a cellular survival signal and ancient mitochondrial communication molecule 4:52–6:55 — Section 1: Humanin as an ancient signal from the mitochondrial genome; 16S rRNA origin, two peptide lengths, evolutionary conservation 6:55–8:04 — Section 2: Alzheimer’s origin story; Humanin as a neuroprotective molecule that interferes with amyloid beta and apoptotic pathways 8:04–9:15 — Section 3: Mitohormesis; Humanin as a stress-responsive mitokine and possible last-ditch survival signal in advanced age 9:15–10:35 — Section 4: Chaperone-mediated autophagy; Humanin as the “supervisor” of cellular cleanup and damaged protein removal 10:35–12:00 — Section 5: Pleiotropic effects beyond the brain: heart, diabetes, metabolism, inflammation, inflammaging 12:00–13:32 — Section 6: Lifespan and health span research; 16% circulating Humanin increase, C. elegans lifespan, FOXO/IGF-1 pathway, and HNG analog 13:32–14:32 — Review conclusion: aging as a breakdown in ancient mitochondrial signaling rather than inevitable wear and tear 14:32–16:26 — Dr. Mike’s viewpoint: Humanin as underappreciated, part of the top three mitochondrial peptides with SS-31 and MOTS-c

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers

-

Key Quotes From Dr. Mike:

“BPC-157 has been investigated primarily through studies looking at gastrointestinal protection, tissue repair, and healing mechanisms.”

“BPC-157’s gastric stability does not equal oral bioavailability… “The claim that oral BPC-157 reaches systemic circulation is an unverified hypothesis, not a clinical fact.”

“It enters the blood, triggers a response, and is cleared by the kidneys almost instantly. Yet its healing effects can persist for days or weeks.”

“There are over 544 peer-reviewed studies, mostly in rodents… In terms of total human efficacy subjects, there’s fewer than 30 people documented in all history.”

“For now, BPC-157 remains the ultimate biological paradox: a compound that can seemingly heal anything in the lab, but officially nothing in the clinic.”

-

Key Points

⚡ BPC-157 stands for Body Protecting Compound 157 and is derived from a protective protein found in human gastric juice.

⚡ It has been studied mostly in animal models for tissue repair, tendon healing, ligament recovery, muscle injury, gut protection, angiogenesis, nerve support, inflammation modulation, and oxidative stress reduction.

⚡ Despite its popularity, BPC-157 has almost no robust human clinical data.

⚡ A recent Pharmaceutics review describes BPC-157 as an investigational peptide with major formulation, pharmacokinetic, regulatory, and translational barriers.

⚡ BPC-157 is unusually stable in acidic stomach-like environments, but gastric stability does not prove oral bioavailability.

⚡ Its systemic half-life appears to be under 30 minutes, yet animal studies suggest effects may last days or weeks, creating a major pharmacokinetic/pharmacodynamic mystery.

⚡ The review suggests BPC-157 may act as a transcriptional primer, briefly triggering gene and growth-factor cascades that continue after the peptide is cleared.

⚡ The evidence base is heavily skewed toward preclinical animal studies, with very limited human data.

⚡ Much of the BPC-157 literature comes from one research group at the University of Zagreb, creating a need for independent replication.

⚡ BPC-157’s native stability may make it difficult to patent, reducing pharmaceutical incentive to fund large clinical trials.

⚡ Current gray-market products are research chemicals, not FDA-approved pharmaceutical-grade human therapeutics.

⚡ Potential risks include inconsistent dosing, lack of GMP oversight, lack of long-term safety data, and theoretical concern around angiogenesis in the setting of hidden malignancy.

⚡ Dr. Mike’s view: BPC-157 has earned scientific curiosity, but not scientific certainty.

-

Episode timeline

0:00 – Introduction to BPC-157 Dr. Mike introduces BPC-157 as one of the most popular peptides outside the GLP-1 category and explains that BPC stands for Body Protecting Compound 157.

0:49 – The Review Being Covered The episode centers on a recent Pharmaceutics review titled BPC 157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers.

1:20 – Brief History of BPC-157 BPC-157 is described as a synthetic peptide derived from a protective protein naturally found in human gastric juice, with research beginning in the 1990s.

2:05 – Anecdotal Use and Recovery Claims Dr. Mike discusses how BPC-157 is often used anecdotally for soft-tissue injuries, chronic pain, muscle strains, tendons, ligaments, cartilage, and athletic recovery.

2:45 – Potential Benefits The episode outlines possible benefits including tendon repair, ligament recovery, muscle healing, wound healing, gut protection, joint support, angiogenesis, inflammation reduction, oxidative stress modulation, nerve regeneration, and overuse injury recovery.

3:36 – Angiogenesis Caveat Dr. Mike notes that while blood vessel formation can support healing, it may theoretically be problematic in the presence of active or hidden cancer.

4:11 – The Phantom Peptide BPC-157 is framed as a paradox: one of the most popular experimental peptides with decades of animal data but almost no validated human evidence.

5:42 – The Gastric Survivor The review highlights BPC-157’s unusual stability in acidic gastric environments, while emphasizing that stomach stability does not equal proven oral absorption.

7:25 – The 30-Minute Phantom Dr. Mike explains the pharmacokinetic/pharmacodynamic disconnect: BPC-157 appears to clear rapidly, yet may trigger longer-lasting biological effects.

8:49 – The 554-to-1 Evidence Gap The episode breaks down the huge imbalance between preclinical studies and human clinical data, including fewer than 30 documented human efficacy subjects.

9:35 – The Zagreb Paradox Much of the BPC-157 literature comes from a single research group at the University of Zagreb, creating a major need for independent replication.

10:15 – Armor Made of Proline BPC-157’s structural durability is explained through its proline-rich sequence, which may help protect it from enzymatic breakdown.

10:47 – Why Big Pharma May Not Be Interested Because BPC-157 is natively stable and difficult to patent as a new chemical entity, there may be limited financial incentive for large pharmaceutical trials.

11:48 – Regulatory Limbo The episode discusses gray-market availability, lack of pharmaceutical-grade versions, research-chemical status, and possible FDA scrutiny.

13:23 – What BPC-157 Needs Next Dr. Mike explains the need for validated LC-MS/MS methods, ICH Q1A stress testing, and independent replication of the Zagreb data.

15:18 – Dr. Mike’s Viewpoint BPC-157 is described as neither miracle nor fraud, but a promising yet uncertain compound that deserves open-minded skepticism.

16:55 – Scientific Curiosity vs. Scientific Certainty The episode closes by emphasizing that BPC-157 has compelling preclinical evidence and strong anecdotal support, but still lacks definitive human evidence.

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

Then we move from theory to action: the episode begins the “applications” section with a practical, research-backed toolkit — red light therapy, methylene blue, blue spirulina, & Carbon 60 — including how they work, how they stack, & why the right strategy is less about “more antioxidants” & more about restoring electron flow, managing oxidative stress, & building cellular resilience.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

“If mitophagy is not working properly, then those damaged mitochondria are allowed to linger and be pro-inflammatory and be pro-oxidative stress.”

“Specifically, red and near-infrared are the spectra that excites the mitochondria and the cytochrome c oxidase. No other wavelengths accomplish this.”

“Simply by exposing your body… to red and near-infrared light (whether sun or red light therapy devices)… this is likely the most powerful way to remedy mitochondrial dysfunction.”

“Methylene blue is one of the only ways I know of that’s able to actually restore energy in mitochondria with broken electron transport chains.”

“We have an amazing natural alternative to methylene blue… and that is blue spirulina, which has phycocyanins that absorbs red light to protect neurons and strengthen our mitochondrial performance.”

“Carbon 60 is essentially a free radical sponge… it’s only gonna remove the excess ‘bad’ free radicals and allow the good signaling molecules to stay.”

-

Key Points

⚡️ Mitophagy = mitochondrial quality control: PINK1 “inspects,” Parkin “tags,” autophagosomes “remove.” When it fails, damaged mitochondria linger & inflammation/oxidative stress snowball.

⚡️ Dysfunctional mitochondria can self-propagate, accelerating decline unless quality control is restored.

⚡️ Mitochondrial dynamics (fusion/fission) is a Goldilocks game:

• Too much fission → fragmentation & energy collapse
• Too much fusion → damage spreading through hyperfusion

⚡️ ROS aren’t “all bad”: low-level ROS are essential signals; the goal is selective antioxidant defense, not blanket quenching.

⚡️ Light is a mitochondrial master regulator: red/NIR stimulate cytochrome c oxidase, dissociate nitric oxide, allow oxygen back in → better ATP + EZ water.

⚡️ Red light therapy is wavelength-driven, not “power-driven”: red = skin; NIR = deeper tissues; power mainly affects time-to-dose.

⚡️ Methylene blue = electron chaperone: bypasses ETC bottlenecks (esp. complex I/III) by shuttling electrons toward complex IV; synergizes with red light.

⚡️ Blue spirulina (phycocyanin) = natural photodynamic partner: less potent than MB but strong synergy with red light; quality matters (E10→E40).

⚡️ Carbon 60 = selective free radical sponge: mops up “excess” ROS while preserving beneficial signaling; quality control is crucial.

-

Episode timeline

• 0:00–2:00 — Why this “Part 2” exists (no event time limit) + recap: bioenergetics + pillars 1–2 from Part 1
• 2:00–8:30 — Pillar 3: Mitophagy (PINK1/Parkin, why failure drives disease, self-propagation, urolithin A mention)
• 8:30–12:45 — Pillar 4: Mitochondrial dynamics (fusion vs fission, benefits, dangers of imbalance)
• 12:45–16:30 — Pillar 5: ROS protection (signal vs damage, selective antioxidants, why “antioxidant overload” backfires)
• 16:30–25:00 — Pillar 6: Light (cytochrome c oxidase, NO vs oxygen competition, why red/NIR are special, darkness as a mitophagy signal)
• 25:00–33:00 — Applications begin: Red light therapy (wavelength vs penetration, power vs efficiency, dosing logic, third-party testing)
• 33:00–41:45 — Methylene blue (electron chaperone + regenerative redox cycling + brain affinity + SSRI nuance + photodynamic synergy)
• 41:45–46:45 — Blue spirulina (phycocyanin, how to use, why E40 matters, timing before light)
• 46:45–54:45 — ESS60 / Carbon 60 (selective ROS sponge, quality warnings, classic longevity study discussion, why it completes the “triad”)
• 54:45–end — Why this becomes a 3-parter + what’s coming next (remaining applications + “Energy Code Blueprint” day/week examples)

-

Introducing BioLight Labs!

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

MOTS-c Functionally Prevents Metabolic Disorders

-

Key Quotes From Dr. Mike:

“MOTS-c… helps regulate cellular energy production, metabolic flexibility, and stress adaptation.”

“MOTS-c functionally prevents metabolic disorders.”

“When the cells are under metabolic stress, MOTS-c… can be rapidly transferred from mitochondria to the nucleus and regulates nuclear gene expression.”

“Because MOTS-c is easily destroyed by digestive enzymes, oral delivery remains a significant challenge…”

“Some researchers view MOTS-c as a mitochondrial distress signal… mitochondria release more MOTS-c when challenged, not when everything is perfectly comfortable.”

“If you want the best of both worlds (for mitochondrial optimization)... stack SS-31 and MOTS-c together.”

-

Key Points

• SS-31 and MOTS-c are framed as the “top two” mitochondrial peptides (SS-31 = not mitochondrially-derived but highly mito-targeted; MOTS-c = mito-derived).
• MOTS-c is positioned as a mitochondrial optimization + metabolic flexibility peptide and an “exercise mimetic.”
• Core benefits highlighted: energy production, glucose utilization/insulin sensitivity, body composition, endurance/recovery, stress adaptation, longevity support.
• Big concept: mitochondria aren’t passive; they signal back to the nucleus. MOTS-c can translocate to the nucleus under metabolic stress and regulate gene expression.
• Mechanism highlighted: MOTS-c disrupts folate–methionine cycle → increases AICAR → activates AMPK → boosts fatty acid oxidation + insulin sensitivity.
• Review claims include: prevention of diet-induced obesity; possible cardiac protection against remodeling (NRG1–ERBB4 pathway mentioned).
• Longevity genetics angle: a mitochondrial polymorphism (noted as prevalent in Japanese population) may alter MOTS-c structure and associate with exceptional lifespan.
• Frailty/bone/muscle: MOTS-c described as inhibiting FOXO1 (muscle wasting signals), supporting myotube formation (STAT3), and reducing osteoclast differentiation (anti-osteoporosis).
• “Endogenous edge”: as a bioidentical peptide, MOTS-c is framed as potentially less immunogenic than some drugs, but oral delivery is a challenge due to peptide fragility.
• Practical close: best endogenous stimuli are mitochondrial challenges—exercise, fasting, heat/cold, hypoxia—plus circadian alignment and mitochondrial support nutrients.

-

Episode timeline

• 0:00–1:55 — Transition from SS-31 to MOTS-c; why MOTS-c is a “top two” peptide; new format: quick primer before the paper
• 1:55–4:33 — MOTS-c snapshot: what it is + core benefits list (metabolism, insulin sensitivity, fat loss, endurance, longevity)
• 4:33–7:57 — Review intro: mitochondria as control centers; retrograde signaling; MOTS-c as a mitochondrial messenger to DNA
• 7:57–10:44 — “Exercise mimetic” mechanism: folate–methionine cycle → AICAR → AMPK; obesity/metabolic protection examples
• 10:44–12:05 — Longevity genetics: MOTS-c polymorphism + “nature vs nurture” discussion
• 12:05–13:52 — Frailty defense: muscle (FOXO1/STAT3), bone (osteoclast suppression; OPG/RANKL mention)
• 13:52–15:46 — Endogenous/bioidentical angle; immune aging + senescent cell clearance; oral delivery limitations
• 15:46–19:31 — How to boost endogenous MOTS-c: exercise intensity, fasted training nuance, AMPK activators, TRE/IF/CR
• 19:31–24:25 — Cold/heat/circadian alignment + mitochondrial support stack (taurine, urolithin A, CoQ10, PQQ, etc.)
• 24:25–26:10 — “Distress signal” nuance: mitochondria release more MOTS-c when challenged
• 26:10–29:41 — Practical stacking: SS-31 first (engine repair) → add MOTS-c; daily timing suggestions; closing message

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function

-

Key Quotes From Dr. Mike:

“The future of Parkinson’s therapy may not lie in cleaning up the mess, but rather in providing our neurons with a permanent molecular shield…”

“SS-31 acts as a molecular shield protecting the brain’s energy supply…”

“SS-31 acts as a molecular bouncer, physically evicting alpha-synuclein from lipid membranes…”

“SS-31 substantially prolonged the lag phase of aggregation, essentially stalling the clock on protein buildup.”

“These findings underscore the multifaceted protective role of SS-31 against mitochondrial dysfunction caused by alpha synuclein aggregation... SS-31 reversed this decline with a 10 micromolar dose…”

-

Key Points

• SS-31 is framed as a mitochondria-first peptide: “restore impaired mitochondrial function” is the headline.
• Parkinson’s pathology is presented as a cellular power failure inside dopaminergic neurons driven by alpha-synuclein toxicity.
• SS-31 may act like a “molecular bouncer” — outcompeting alpha-synuclein for anionic lipid membranes and preventing harmful binding/folding.
• The episode highlights the real-world complication: N-terminal acetylated alpha-synuclein (common in humans) embeds deeper and is harder to displace.
• SS-31 appears to delay aggregation kinetics (longer “lag phase”) and shift aggregate morphology toward potentially less toxic off-pathway forms.
• Mitochondrial function was assessed with a Seahorse mito stress test; SS-31 is described as restoring basal/max respiration (at a cited 10 μM dose).
• Mechanistically, SS-31 is explained as:
  1. Cardiolipin binding → supports OXPHOS efficiency/ATP output
  2. ROS scavenging (tyrosine residue) → reduces oxidative damage
• SS-31 may also reduce alpha-synuclein oligomer uptake by altering membrane electrostatics (less negative surface charge).
• A major warning: very high concentrations (described as >100 μM) may trigger apoptosis / reduce viability.
• Big-picture: SS-31 supports a “prevention-first” strategy — block the lipid–protein interaction upstream, rather than “cleaning up the mess” later.

-

Episode timeline

• 0:00–0:40 — Why peptides are the next major content focus; why SS-31 is the first peptide deep dive
• 0:40–3:55 — Paper intro + “SS-31 restores impaired mitochondrial function” framing; what the show will cover and why it matters
• 3:55–5:44 — Parkinson’s as mitochondrial “power failure”; alpha-synuclein as the driver; SS-31 as a BBB-permeable candidate
• 5:44–6:58 — Takeaway #1: SS-31 as a “molecular bouncer” displacing alpha-synuclein from membranes (dose-dependent)
• 6:58–8:16 — Takeaway #2: N-terminal acetylation makes alpha-synuclein “stickier” and harder to displace (real-human relevance)
• 8:16–9:40 — Takeaway #3: Aggregation kinetics + morphology shifts (stalling the “snowball”)
• 9:40–11:40 — Takeaway #4–#5: Respiration rescue + membrane/cell-entry effects; the dual mechanism (cardiolipin + ROS)
• 11:40–13:20 — Dose caution, wrap-up, and the “designer peptides” future-forward conclusion

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

“The more energy you produce per cell, the more vitality you will have... The less energy you produce per cell, the closer to a state of disease you will be.”“Around 80% of modern diseases are directly tied to mitochondrial dysfunction.”“Any wellness strategy that involves harnessing electrons is inherently anti-aging.”“Epigenetics is rooted in the mitochondria. They sense your environment and then send signals to the cell nucelus, which then turns genes on/off based on those mitochondrial signals."“Cardiolipin… is like the bedrock of mitochondrial function... Many researchers now believe cardiolipin deterioration is one of the central hallmarks of mitochondrial aging.”“SS-31’s mission is to fix and repair and prevent damage to cardiolipin. This makes SS-31 the MOST IMPORTANT peptide for mitochondrial function and anti-aging, from the bioenergetic perspective."“After the age of 30, we typically lose about 1% of energy production annually.”“Mitochondrial decline drives the hallmarks of aging... The future is clearly bioenergetic.”

-

Key Points

-

Episode timeline

-

Introducing BioLight Labs!

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Mitoredox shifts in mitochondrial dysfunction

-

Key Quotes From Dr. Mike:

“Mito-redox shifts… serve as a central link between oxidative stress and various diseases.”

“These shifts destabilize essential cellular processes such as mitophagy and mitochondrial DNA stability…”

“We are entering an era of mito redox medicine where we manage the electron flow of life itself.”

“The retina is the only part of the central nervous system that can be imaged non-invasively… Whereby fluorescence imaging can detect metabolic failures years before physical symptoms appear… that is game changing.”

“Life is defined by the steady controlled flow of electrons… when that flow is disrupted… our mitoredox shifts towards mitochondrial dysfunction and, ultimately, disease."

-

Key Points

• The review frames mitoredox shifts as a central link between oxidative stress and diverse diseases.
• Distinguishes primary mitochondrial syndromes (genetic) vs secondary disorders (environmental/metabolic)—with secondary being far more common.
• Mitoredox shifts destabilize mitophagy + mtDNA stability, leading to dysfunctional organelle buildup and cell death.
• The shift acts like an upstream master switch, biasing cells toward regulated death programs (e.g., ferroptosis, cuproptosis).
• “Healthy mitochondria can be hyperactive”: compensatory overwork can spike ROS and accelerate heteroplasmic drift.
• Heteroplasmy threshold: symptoms often emerge when mutated mtDNA crosses ~60–80%.
• Proposed takeover mechanisms: faster replication of truncated genomes, mitophagy decline, “survival of the sickest” evasion, random drift.
• Reperfusion paradox: restoring oxygen after ischemia can trigger a ROS surge that worsens injury and inflammation.
• Diagnostics: biomarkers + retinal imaging/oculomics, with AI methods potentially detecting dysfunction yearsearly.
• Therapeutics: mitochondrial transplantation, novel redox modulators (e.g., PMX 500FI), and “electron-flow stabilization” strategies.

-

Episode timeline

• 0:00–0:20 — Intro + review title + journal + preprint context (publishing Sept 2026)
• 0:20–1:22 — New format: TL;DR first, then deeper dive
• 1:22–2:56 — TL;DR: mitoredox shifts as the bridge between oxidative stress and disease; primary vs secondary; diagnostics + therapies; goal = restore homeostasis
• 3:00–5:01 — Mythology + endosymbiosis framing: “bioenergetic fire,” mitochondria as life/death controllers
• 5:01–6:58 — Concept 1: Mitoredox shift as the “unified field theory” linking ROS/antioxidants, QC failure, genome instability, regulated cell death
• 7:03–9:05 — Concept 2: “Healthy mitochondria” hyperactivity + metabolic asymmetry + heteroplasmic drift
• 9:05–11:59 — Concept 3: 60–80% tipping point; takeover mechanisms; aerobic glycolysis as a “stealth” adaptation
• 11:59–13:38 — Concept 4: reperfusion paradox; ROS overload → vascular destabilization + inflammation; eye/oculomics relevance
• 13:41–18:26 — Concept 5: future interventions—mito transplantation, AI oculomics, redox drugs (PMX 500FI) + Mike’s redox “triad” (RLT/MB/C60)
• 18:26–19:25 — Closing: mitochondria as redox arbiters; “electron flow of life” question + final thought

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction

-

Key Quotes From Dr. Mike:

“For decades, the medical establishment has approached AFib as an electrical failure…The true culprit may not be the wiring, but rather the power plants.”

“In patients with atrial fibrillation, these protective peptides essentially vanish... The more severe the peptide depletion, the more advanced the structural damage appeared to be.”

“Our study identifies down regulation of Humanin and MOTS-c as a novel feature of human afib that correlates with fibrosis... As Humanin and MOTS-c levels drop, collagen deposition and atrial fibrosis increase.”

“Humanin predominantly influences cell adhesion and immune response pathways, while mots C targets metabolic processes... They effectively attenuated structural remodeling and significantly reduced afib inducibility…”

“These micropeptides are born directly within the mitochondrial DNA... They are exercise sensitive myokines, meaning physical activity naturally stimulates their production.”

-

Key Points

• The featured paper (May 5, Biomedicines): Humanin + MOTS-c attenuate AFib by suppressing fibrosis and mitochondrial dysfunction.
• AFib is framed as a growing societal burden and a driver of stroke/heart failure; current therapies mainly manage the “wiring.”
• Humanin + MOTS-c are mitochondrial-derived peptides encoded in mtDNA, acting as cytoprotective stress messengers.
• AFib atrial tissue shows significant downregulation of both peptides (spatial transcriptomics + histology).
• Severity link: more depletion → more structural damage/fibrosis.
• Biomarker link: plasma MOTS-c is decreased and inversely correlates with NT-proBNP.
• The “Humanin paradox”: Humanin depleted in atrial tissue but slightly elevated in plasma — blood levels can mislead.
• In a mouse model, HNG (Humanin analog) + MOTS-c reduced AFib inducibility and structural remodeling.
• Mechanistic themes: preserved mitochondrial ultrastructure, normalized fission dynamics, reduced hypertrophy, lowered IL-1β and IL-6.
• Dual-pronged fibroblast control: Humanin influences adhesion/immune pathways, MOTS-c targets metabolic pathways.

-

Episode timeline

• 0:00–0:57 — Intro: peptide-focused season; “future of mitochondrial medicine”
• 0:57–2:32 — Paper setup + personal relevance; why AFib is a mitochondria-dense tissue problem
• 2:32–3:50 — Reframing AFib: from electrical “wiring” to mitochondrial “power plants” + micropharmacology
• 3:50–4:56 — Humanin + MOTS-c basics: mtDNA-encoded “guardians,” exercise-sensitive signaling
• 4:56–6:51 — Human atrial tissue findings: downregulation, severity correlation, MOTS-c vs NT-proBNP
• 6:51–7:56 — Fibrosis link + RAAS context; peptides as complementary anti-scarring pathway
• 7:56–9:47 — Mouse model: HNG + MOTS-c outcomes (ultrastructure, fission, hypertrophy, cytokines)
• 9:47–11:15 — The Humanin paradox: plasma vs tissue concentration; biomarker caution
• 11:15–12:20 — Fibroblast behavior + RNA-seq: Humanin vs MOTS-c “two angles”
• 12:20–13:26 — Synthesis + limitations + closing question (“fueling the cell” paradigm)

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Effect of mitochondrial dysfunction on scar formation after spinal cord injury

-

Key Quotes From Dr. Mike:

“What if the real reason the nerves can’t heal is actually a microscopic energy crisis?”

“This entire battle is governed by the powerhouses of our cells, the mitochondria.”

“In a severe spinal cord injury, that recycling process… mitophagy… completely fails.”

“SS-31… physically binds and stabilizes the cardiolipin… preventing cytochrome C release... It acts like an emergency fuel drop.”

“The answer lies in sustained mitochondrial failure.”

-

Key Points

• SCI disability isn’t only the “cut” — it’s the secondary metabolic battle that follows.
• Early glial scar formation is protective: it walls off necrotic tissue and contains inflammation.
• Acute mitochondrial rupture causes ATP drop + moderate ROS burst that acts as an alarm:
  • ROS → STAT3 activation in astrocytes (glial boundary)
  • ROS → TGF-β1 activation in fibroblasts (ECM deposition)
• Chronic problem: mitophagy failure leaves fragmented mitochondria leaking mtDNA + excess ROS.
• Leaked mtDNA looks “bacterial,” driving sterile inflammation via NLRP3 and sustained microglial activation.
• Chronic inflammatory signaling stabilizes HIF-1α → fibrosis hardens; astrocytes secrete CSPGs that repel axon regrowth.
• Regenerating axons fail via growth cone collapse from local ATP scarcity + toxic environment.
• Interventions target the power grid, not just the scar:
  • MitoQ (TPP “VIP pass” into mitochondria) scavenges ROS at the source.
  • SS-31 stabilizes cardiolipin → prevents cytochrome-c leak/apoptosis.
  • AMPK agonists + NAD+ precursors (NMN/NR) boost energy + suppress NF-κB inflammation.
  • DRP1 inhibitors / MFN2 agonists restore fission–fusion balance.
  • PINK1/Parkin + BNIP3/NIX reboot mitophagy and clear damaged mitochondria.
  • “Sci-fi tier”: mitochondrial delivery (nanocarriers, MSC exosomes, iPSCs) + mtDNA base editing (DDCBE via AAV).
• Translational bottleneck: spatiotemporal timing — block scarring too early and you remove the protective “sandbag wall.”

-

Episode timeline

• 0:19–1:30 — Premise: paralysis as a secondary energy crisis; 2026 Frontiers in Neurology review introduced
• 1:30–2:31 — Shift from structural damage to metabolic pathology
• 2:31–5:20 — Acute phase: mitochondrial rupture → ATP drop + ROS alarm → STAT3 astrocytes + TGF-β1 fibroblasts → protective boundary
• 5:20–6:49 — Why the protective wall becomes a permanent roadblock: sustained mitochondrial failure
• 6:49–9:47 — Mitophagy failure → mtDNA/ROS leak → “false infection” → NLRP3, HIF-1α fibrosis, CSPGs, growth cone collapse (ATP starvation)
• 9:47–12:54 — Targeted mitochondrial pharmacology: MitoQ delivery logic; SS-31 cardiolipin stabilization
• 12:54–13:55 — Metabolic reprogramming: AMPK agonists + NAD+ precursors → energy support + NF-κB suppression
• 13:55–16:45 — Dynamics + cleanup: DRP1/MFN2 tuning; PINK1/Parkin, BNIP3/NIX mitophagy + ubiquitin “barcode” clearance
• 16:45–19:55 — “New hardware” strategies: mito-nanocarriers, MSC exosomes, iPSCs; mtDNA editing (DDCBE/AAV), HDAC inhibitors, ncRNAs
• 19:55–20:53 — The timing problem: preserve early protective scar, prevent later inhibitory scar
• 20:53–22:23 — Final synthesis + fibrosis crossover question; close

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Natural compounds targeting mitochondrial metabolism in cancer therapy: a literature review

-

Key Quotes From Dr. Mike:

“Natural compounds… can actually be weaponized against the very unique way a cancer cell feeds itself.”

“The tumor massively overproduces those BCL2 bouncers... CBD aggressively drains that battery… the BCL2 bouncers literally lose their grip.”

“Curcumin… clogs the exhaust pipes until the factory suffocates on its own fumes.”

“Resveratrol… triggers what we call lethal mitophagy.”

“EGCG doesn’t just attack the power plant, it cuts off the supply lines entirely.”

“Gold nanoparticles are… microscopic armored vehicles... It’s basically a Trojan horse made of gold.”

-

Key Points

• Cancer mitochondria aren’t “broken” (Warburg was incomplete) — tumors reprogram mitochondria into biosynthetic superfactories.
• Tumors rely on fatty acid oxidation and often become glutamine-addicted to feed the TCA “manufacturing hub.”
• Mitochondria also control apoptosis; cancer survives by overexpressing BCL-2 to block BAX/BAK pore formation and cytochrome c release.
• Mitophagy is a paradox: early tumor suppression vs. later survival cannibalism under hypoxia/starvation.
• Natural compounds target key failure points:
  • CBD: drops mitochondrial membrane potential → releases apoptotic blockade.
  • Curcumin: amplifies ROS + mtDNA damage → mitochondrial rupture/apoptosis.
  • Resveratrol: pushes mitophagy into lethal overdrive.
  • EGCG: blocks glutamine utilization (cuts supply lines).
  • Fucoidan: reduces anti-apoptotic defenses across multiple proteins.
  • Marine/fungal agents: uncoupling, ETC complex blockade, ER stress cascades.
• Biggest barrier: bioavailability + rapid metabolism (“forgot the zip code”).
• Solutions: drug hybrids/conjugates, gold nanoparticles, nanocarriers, and synthetic biology fermentation for scalable supply.
• Final provocative arc: if we can deliver payloads to kill tumor mitochondria, can we use the same delivery logic to repair mitochondria in aging?

-

Episode timeline

• 0:19–1:18 — Hook + episode premise: nature as an anti-cancer weapons lab; source paper introduced
• 1:18–2:25 — Why this matters: cancer scale + limits of “blunt instrument” therapies
• 2:25–4:24 — Warburg effect explained (glycolysis “backup generators”) and why the old assumption misled the field
• 4:24–6:31 — Metabolic reprogramming: mitochondria as tumor superfactories; fatty acid oxidation + glutamine dependence
• 6:31–9:15 — Apoptosis control: BCL-2 “bouncers,” BAX/BAK “cops,” cytochrome c “fire alarm”
• 9:15–10:59 — Mitophagy paradox: tumor suppression → survival cannibalism in hypoxic/starved tumor cores
• 10:59–15:18 — Plant compounds mechanics: CBD (voltage), curcumin (ROS), resveratrol (lethal mitophagy), EGCG (glutamine blockade)
• 15:18–19:07 — Marine + fungal compounds: fucoidan; sponge uncouplers; ER-stress triggers; ETC complex blockers
• 19:07–20:48 — The “zip code” problem: bioavailability, metabolism, delivery failure in humans
• 20:48–23:19 — Delivery solutions: conjugates/hybrids, gold nanoparticles, nanoencapsulation
• 23:19–24:30 — Scaling without ecosystem damage: synthetic biology “brew the medicine”
• 24:30–26:21 — Final synthesis + aging crossover question (deliver killers vs. deliver repair)

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Articles Referenced in Episode:

-

Key Quotes From Episode:

“Mitophagy… means the body’s process for identifying damaged mitochondria, removing them, and making room for healthier mitochondria to take their place.”

“When mitochondrial cleanup fails, the cell doesn’t just lose energy — it becomes inflamed, stressed, and vulnerable to disease.”

"Mitochondrial quality control is not a side issue. It may be one of the central mechanisms that determines whether high-demand tissues stay resilient or begin to fail.”

“A healthy cell is always asking: which mitochondria are still efficient, and which ones are leaking too much oxidative stress?”

“Mitophagy is the process that removes the liabilities.”

“Damaged mitochondria are not just weak energy producers. They can actually become inflammatory.”

-

Key Points

• Autophagy = general cellular recycling; mitophagy = targeted recycling of damaged mitochondria.
• Mitochondria are dynamic networks, not static “batteries” — they’re constantly tested, repaired, fused/fissioned, and removed.
• Damaged mitochondria don’t just make less ATP—they can trigger sterile inflammation by leaking ROS, mtDNA, cardiolipin, etc.
• Fabry disease heart model: lysosomal dysfunction → impaired mitophagy → damaged mitochondria → less ATP + more ROS → worse lysosome function (a mito–lysosomal vicious cycle).
• Inflammatory cardiovascular disease: damaged mitochondria activate inflammatory pathways (e.g., NLRP3) and worsen vascular/heart pathology.
• Ophthalmology: retina is extremely energy-hungry; mitophagy failure contributes to glaucoma/AMD/diabetic retinopathy vulnerability.
• Shared “cast” across tissues: PINK1/Parkin, BNIP3/NIX/FUNDC1, AMPK–mTOR, sirtuins, FOXO3, PGC-1α(cleanup + rebuilding).
• The winning strategy isn’t “maximize mitophagy” — it’s balanced flux: remove damaged mitochondria and replace them via biogenesis.

-

Episode timeline

• 00:00–03:30 — Cold open: why mitophagy changes how you think about aging, heart health, eye health, inflammation, energy
• 03:30–09:00 — Definitions: autophagy vs mitophagy + “city waste management” analogy
• 09:00–14:30 — Core principle: damaged mitochondria as inflammatory triggers (sterile inflammation)
• 14:30–27:30 — Paper 1 (Fabry + heart): lysosome impairment → impaired mitophagy → early mitochondrial dysfunction → vicious cycle; early-before-symptoms concept
• 27:30–39:30 — Paper 2 (inflammatory cardiovascular disease): mtDNA/ROS danger signals → NLRP3 + immune activation; mitophagy as anti-inflammatory defense
• 39:30–49:00 — Paper 3 (eye disease): retina energy demand; mitophagy failure in glaucoma/AMD/diabetic retinopathy; why visual tissues are vulnerable
• 49:00–54:30 — Unified model: “high-demand tissues + failed cleanup = energy loss + chronic inflammation + degeneration”
• 54:30–56:12 — Final synthesis: mitophagy = energy defense + immune regulation; “removal + renewal” rhythm

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

Facebook

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Effect of photobiomodulation on pain relief and functional improvement in fractures: a systematic review and meta-analysis

-

Key Quotes From Dr. Mike:

“At the 1-week mark… pain scores were significantly lower in the group receiving photobiomodulation.”

“At 4 weeks out… grip strength was significantly greater in the light therapy group.”

“The risk of experiencing severe sleep-disrupting nocturnal pain was cut exactly in half.”

“Photobiomodulation primarily targets the acute inflammatory phase.”

“When you irradiate the fracture site directly… you’re acting locally… But laser acupuncture acts systemically.”

-

Key Points

• PBM is photochemical, not photothermal — it’s not a heating pad.
• Mechanism centers on cytochrome c oxidase (mitochondria) → ↑ATP + signaling (NO, Ca²⁺, low “healthy” ROS).
• Acute pain reduction is strongest at ~1 week vs. sham treatment (VAS/NRS).
• Nocturnal pain risk cut ~in half (reported risk ratio ~0.49) → major quality-of-life and recovery leverage.
• Upper-limb fractures: ~+5 kg grip strength improvement around week 4 vs placebo.
• PBM can work locally (fracture site) and systemically (laser acupuncture points) via neurochemical pain pathways (endorphins, serotonin/norepinephrine, spinal gating/DNIC).
• Long-term (4–26 weeks): differences in pain/function often wash out as recovery enters remodeling phase.
• Evidence for faster radiographic bone healing is inconsistent across trials.
• Energy density window for analgesia looks broad; wavelength matters more (NIR penetrates deeper than red).
• Big gap: trials largely didn’t measure angiogenesis endpoints, which may matter for longer-term remodeling.

-

Episode timeline

• 0:19–1:26 — Fracture scenario + why alternatives to NSAIDs/opioids matter
• 1:26–2:51 — Source setup: 2026 systematic review/meta-analysis (12 RCTs; 5 countries; ~500 patients)
• 2:51–4:16 — “Not a heating pad”: photochemical vs photothermal PBM
• 4:16–6:12 — Mechanism: mitochondria → cytochrome c oxidase → ATP + NO/Ca²⁺/low ROS signaling
• 6:12–7:55 — Why fractures hurt: periosteum + inflammation + swelling + spasm; NO → microcirculation + waste clearance
• 8:19–9:18 — Main early outcome: lower pain at 1 week (VAS/NRS; sham-controlled)
• 9:21–10:30 — Function: grip strength improved at 4 weeks (+5 kg) in upper-limb fractures
• 10:41–13:56 — Local PBM vs laser acupuncture: endorphins + neurotransmitters + spinal “circuit breaker” (DNIC)
• 14:20–16:23 — Why effects fade later: PBM targets acute inflammatory phase more than long remodeling
• 16:53–17:38 — Radiographic healing: inconsistent evidence for faster cortical bridging/BMD
• 18:43–21:05 — Parameters: broad effective energy-density range for analgesia; NIR penetrates deeper than red
• 21:12–22:24 — Missing metrics: angiogenesis not evaluated in included trials
• 22:36–23:09 — Long-term tracking tools (e.g., PRWE) vs simple pain scales
• 23:14–24:18 — Nocturnal pain finding: risk ratio ~0.49 (sleep-disrupting pain roughly halved)
• 24:41–26:15 — Synthesis: best-supported benefits + what PBM isn’t (not proven to speed full bone knitting)
• 26:33–27:36 — Closing question: why isn’t this standard in trauma care yet?

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

Using the paper “GLP-1 receptor and mitochondria contact sites: an emerging mechanism of metabolic regulation,” Dr. Mike and Don explain how chronic metabolic stress can sever a ~20-nanometer communication bridge between the endoplasmic reticulum (cellular “factory”) and mitochondria (cellular “power plant”). Then they explore a provocative idea: GLP-1 receptor agonists may work partly by forming localized “signalosome” hubs at these contact sites — boosting cAMP right where it’s needed — to upregulate MFN2, a tethering “winch” that helps pull fragmented mitochondria back into proper contact and restore calcium/lipid exchange and metabolic flexibility.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

GLP-1 receptor and Mitochondria-ER Contact Sites: an emerging mechanism of metabolic regulation

-

Key Quotes From Dr. Mike:

“The paper introduces a breakthrough concept here called signalosomes.”

“GLP-1 receptors physically organize into specialized, highly concentrated hubs… directly at the site of the severed connection.”

“Could targeting these microscopic contact sites hold the key to reversing the cellular decay of aging itself?”

“When your body enters a state of chronic metabolic dysfunction, the stress acts like a biochemical wrecking ball inside that factory.”

“These GLP-1 therapies are far more than just systemic appetite suppressants… They are literal microscopic architects.”

-

Key Points

• Metabolic disease may involve physical disruption of ER–mitochondria contact sites (mito-ERCS), not only “slow metabolism” in a vague sense.
• The paper frames mito-ERCS as a ~20 nm bridge enabling critical ER↔mitochondria communication.
• Chronic stress is described as triggering an ATF4 → PDE4D → cAMP degradation cascade, contributing to bridge failure.
• When contact sites fail, mitochondria can fragment, contributing to an “energy crash” phenotype.
• GLP-1 receptors may assemble into localized signalosomes at mito-ERCS — targeting repair rather than broadcasting diffuse signaling.
• Local cAMP signaling can promote MFN2 upregulation, helping re-tether mitochondria back to ER at the correct distance.
• Restored contact sites may normalize calcium and lipid transfer, supporting metabolic flexibility.
• Big takeaway: GLP-1s may be cellular architects, not just appetite suppressants — raising the question of whether “contactomics” could extend into aging biology.

-

Episode timeline

• 0:19–0:41 — Intro: metabolic treatment isn’t just “scale changes”; we’re going microscopic
• 1:00–1:18 — Grounding paper: GLP-1 receptor + mitochondria contact sites as metabolic regulation
• 1:34–2:11 — Core architecture: ER as “factory,” mitochondria as “power plant,” bridged by ~20 nm contact sites
• 2:11–3:18 — Metabolic collapse model: chronic stress → ATF4 → PDE4D → cAMP loss → contact sites sever + mitochondrial fragmentation
• 3:27–4:20 — Main question: how do GLP-1 therapies fix a precise structural failure without chaotic signaling?
• 4:09–4:56 — “Signalosomes”: GLP-1 receptors form concentrated hubs at mito-ERCS (targeted repair zone)
• 4:56–5:36 — Local cAMP boost → MFN2 upregulation: the “winch” that re-tethers and rebuilds the bridge
• 5:36–6:25 — Function restored: calcium/lipid exchange resumes; factory + power plant back online
• 6:25–7:13 — Bigger implication: GLP-1s as “microscopic architects”; does contactomics extend to aging?

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Articles Referenced in Episode:

-

Key Quotes From Episode:

“Mitohormesis is essentially weightlifting for your cellular engines.”

“The very thing causing the damage… is the required key to turn on the system that builds the fire extinguishers.”

“Regular physical exercise is, at its core, a mitohormetic stressor.”

“If you hit an optimal threshold of mild to moderate mitochondrial stress… it triggers a beneficial, highly active adaptive response.”

“We need to start looking at [mitochondria] as the master environmental sensors of the entire human body.”

-

Key Points

• Mitohormesis = a nonlinear (bell-curve) response:
  • too much stress → mitochondrial rupture → inflammation → apoptosis
  • too little stress → no upgrades (stagnation)
  • “just right” stress → adaptive reprogramming → resilience + longevity
• Mitochondria are framed as environmental sensors, not just ATP factories.
• Key triggers: ROS, misfolded proteins, hypoxia, fasting/substrate deficiency, mtDNA mutations.
• Core “fire alarm” signaling described: OMA1 cleaves DLE1 → DLE1S activates HRI → eIF2α → ATF4 → DNA-level survival reprogramming.
• ATF4 shifts metabolism, boosts amino acid import, supports DNA repair via one-carbon metabolism, restores redox balance via endogenous antioxidants (e.g., glutathione).
• Built-in redundancy: “import arrest” still triggers ISR when DLE1 accumulates outside the mitochondria.
• Systemic mitohormesis: stressed tissues secrete mitokines that upgrade distant organs.
• Examples:
  • FGF21 → higher energy expenditure + fat metabolism signaling
  • GDF15 crosses BBB → appetite/taste aversion (energy conservation + toxin avoidance)
  • MOTS-c → improves metabolic homeostasis + exercise capacity
  • NAT (N-acetyl-L-tyrosine) → induces tiny ROS burst → activates FOXO/KEAP1/Nrf2 defense axis
• Exercise is framed as the most reliable, natural Goldilocks stressor: ROS + low ATP + hypoxia → ISR/mitokines → whole-body resilience.
• Stem cells live in hypoxic “seed vault” niches to preserve stemness and avoid ROS damage; differentiation requires fusion → OXPHOS surge → ROS signal.
• Dark side: cancer can hijack mitohormesis → therapeutic resistance; precision medicine must both trigger and block these pathways contextually.

-

Episode timeline

00:00:37–00:02:25 — The paradox: stress/toxins/starvation can upgrade cells → mitohormesis defined 00:02:25–00:04:34 — Research stack overview (Gunawan 2025; Barzegari 2022; Cheng/Liu/Finkel 2024; Gohil/Singh 2021; Boet 2024) + thesis: mitochondria as sensors 00:04:46–00:06:40 — Hormesis history + “dose makes the poison” → bell curve explained 00:06:40–00:10:23 — Three zones: catastrophic failure vs stagnation vs Goldilocks adaptation; strength-training analogy 00:10:23–00:13:32 — “Cellular dumbbells”: ROS, misfolded proteins, hypoxia, fasting, mtDNA mutations 00:13:32–00:24:28 — How mitochondria signal the nucleus: UPRmt + ISR; deep dive into OMA1 → DLE1 → HRI → eIF2α → ATF4 + redundancy via import arrest 00:24:28–00:29:31 — From one cell to the whole organism: systemic mitohormesis + mitokines 00:29:31–00:33:10 — NAT discovery (army worm → humans): controlled ROS “match” → KEAP1/Nrf2 defense amplification 00:33:10–00:37:28 — Exercise redefined: mitohormetic stressor → mitokines → whole-body upgrades + white fat browning 00:37:28–00:47:44 — Stem cell fate (Barzegari 2022): hypoxic niches, HIF1α, glycolysis, “seed vault” model; fusion/fission dictates stemness vs differentiation 00:47:44–00:49:55 — Dark pivot: cancer hijacks mitohormesis → therapeutic resistance; Warburg framing introduced 00:49:56–00:58:34 — Aging/Alzheimer’s + interventions: “ring the alarm”; urolithin A (postbiotic → mitophagy); antioxidant paradox setup + Ristow 2009 (C+E blunting exercise adaptation) 00:58:34–01:02:17 — Synthesis: mitochondria as sentries; precision medicine = manage Goldilocks zone; modern comfort “signal deprivation” question

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

Facebook

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Effects of fullerenol C60 on the liver, heart and brain tissues of streptozotocin‑induced diabetic rats with sepsis

-

Key Quotes From Dr. Mike:

"Think of sepsis as a massive fire breaking out in a house… and diabetes like having gasoline already spilled all over the floor."

Regarding C60: “It has this amazing capacity to attract and neutralize rogue, unbalanced electrons from free radicals.”

“In the liver, there was vastly reduced hepatocyte necrosis.”

“In the heart, they saw reduced interstitial fibrosis and way less myocardial disorganization.”

“They noted a major decrease in inflammatory cellularity in the brain.”

“It’s (C60) not just blocking the fire—it’s like upgrading the body’s sprinkler system.”

-

Key Points

• Diabetes pre-loads the system with oxidative stress, making sepsis dramatically more damaging.
• The model: polymicrobial sepsis via CLP in diabetic rats.
• “Regular” C60 is insoluble/toxic in biology, but hydroxylated C60 becomes water-soluble and biologically usable.
• Mechanism frame: C60 as an “aggressive electron sink” that neutralizes free radicals and mimics SOD-like activity.
• Marker shift: TBARS ↓ (less lipid peroxidation / less membrane damage).
• Organ protection signals:
  • Liver: necrosis ↓; AST/ALT/GGT/bilirubin ↓
  • Heart: fibrosis ↓; myocardial disorganization ↓
  • Brain: inflammatory cellularity ↓ (macrophages, astrocytes)
• Not just a shield: catalase activity ↑, suggesting support of native defenses.
• Closing provocation: could daily use in vulnerable populations precondition organs against oxidative storms?

-

Episode timeline

• 00:00:19–00:00:52 — Show intro + mission: C60 study + sepsis organ failure in diabetics
• 00:00:52–00:01:42 — Model setup: diabetic rats + polymicrobial sepsis via CLP
• 00:01:42–00:02:26 — Why diabetes worsens sepsis: chronic hyperglycemia → higher ROS baseline (“gasoline on the floor”)
• 00:02:26–00:03:28 — Key chemistry: insoluble/toxic C60 vs hydroxylated, water-soluble C60
• 00:03:28–00:04:28 — Mechanism: nanoscale “soccer ball” + alternating bonds → electron sink / SOD-mimic framing
• 00:04:28–00:04:59 — Oxidative damage readout: TBARS ↓ → lipid peroxidation reduced
• 00:04:59–00:05:37 — Liver protection: necrosis ↓; enzymes (AST/ALT/GGT/bilirubin) ↓
• 00:05:37–00:05:58 — Heart protection: fibrosis ↓; myocardial disorganization ↓
• 00:05:58–00:06:05 — Brain protection: inflammatory cellularity ↓ (macrophages/astrocytes)
• 00:06:05–00:06:29 — Endogenous defenses: catalase activity ↑ (“upgrading the sprinkler system”)
• 00:06:29–00:07:25 — Takeaway + global sepsis scale + provocative prevention question (daily prophylaxis?)

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

The Mitochondrial Permeability Transition Pore: Past, Present, and Future

-

Key Quotes From Dr. Mike:

“For decades, the exact molecular identity of the self-destruct mechanism was a huge mystery in biophysics.”

“Your mitochondria actually have exactly that — a built-in kill switch.”

“When your mitochondria get overwhelmed by too much calcium, they can open up the permeability transition pore.”

“You can picture it as a literal finger hooking into a fatty lipid plug... When there’s a massive overload of calcium, that structural finger just pulls the plug.”

“We are basically carrying around a vital energy machine that moonlights as an executioner.”

-

Key Points

• The PT pore is framed as a mitochondrial kill switch that opens under extreme stress (notably calcium overload).
• Modern consensus points toward ATP synthase as the structural basis of the PT pore.
• “Death finger” model: ATP synthase subunit-e acts like a finger pulling a lipid plug — turning an energy machine into a destructive leak.
• Cyclophilin D (CypD) behaves like a foreman, helping order the pore to open.
• Inorganic phosphate is the paradoxical accelerator: despite binding calcium, it changes CypD’s binding behavior, promoting pore opening.
• Some species (e.g., Artemia franciscana / brine shrimp) appear to lack functional PT pore, tolerating huge calcium loads and hypoxia.
• Brine shrimp subunit-e has ~15 extra amino acids, creating “slack” that prevents the plug from being pulled.
• If we can mimic that “relaxed tension,” we may reduce reperfusion injury after stroke/heart attack.

-

Episode timeline

• 00:00:19–00:00:59 — Setup: mitochondria as power plants… with a surprise self-destruct button
• 00:01:00–00:01:34 — PT pore basics: calcium overload → swelling, energy collapse, death signaling
• 00:01:35–00:02:31 — ATP synthase as the likely pore-former: “hydroelectric dam” turning into a floodgate
• 00:02:32–00:03:20 — “Death finger” model: subunit-e + lipid plug → drain pulled open
• 00:03:21–00:04:46 — CypD + inorganic phosphate paradox: the “calming” molecule that helps open the gate
• 00:04:47–00:05:27 — Evolution question: if this kills cells, why wasn’t it removed?
• 00:05:28–00:05:57 — Brine shrimp (sea monkeys): mitochondria tolerate calcium/hypoxia without PT pore activation
• 00:05:58–00:06:32 — The structural hack: +15 amino acids on subunit-e = slack that prevents unplugging
• 00:06:33–00:07:22 — Clinical relevance: reperfusion injury + the hope of mimicking “relaxed tension” in humans
• 00:07:23–00:07:37 — Wrap + closing thought: maybe the kill switch has a purpose we don’t fully understand (yet)

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Dose-dependent effects of methylene blue on hemodynamics, cytokines, oxidative stress, and organ dysfunction in a rat model of CLP-induced sepsis: An experimental study

-

Key Quotes From Dr. Mike:

“In emergency medicine, the instinct is always to overpower the crisis with brute force.”

Regarding vasoplegia: "The engine driving it is an overproduction of nitric oxide.”

“Methylene blue… oxidizes the heme iron… preventing nitric oxide from binding to sGC.”

“It (methylene blue) restores normal vascular tone without aggressively squeezing the vessel from the outside.”

“At super-therapeutic concentrations, methylene blue stops acting as an efficient electron carrier... Instead of smoothly passing electrons… it begins indiscriminately stealing electrons and auto-oxidizing.”

“That is the inherent danger of redox-active compounds.”

-

Key Points

• Septic shock punishes “brute force” care: raising MAP can collapse microvascular perfusion and accelerate organ failure.
• Core driver of vasoplegia: iNOS → excess NO → sGC activation → cGMP surge → vascular smooth muscle relaxation.
• Standard vasopressors “fight from the outside,” risking regional hypoperfusion, ischemia, and organ injury.
• Methylene blue “fixes from the inside”: prevents NO binding to sGC (heme oxidation) and reduces NO production.
• In CLP sepsis (dynamic polymicrobial model), 10 mg/kg improved MAP and organ protection without high-dose pressors.
• Cellular redox rescue: ↑ SOD/GSH, ↓ MDA (lipid peroxidation), ↓ IL-1β.
• Dose is everything: at high concentrations methylene blue becomes pro-oxidant, generating ROS and worsening collapse.
• Translational scaling: 10 mg/kg (rat) ≈ 1.6 mg/kg (human), within the clinical bolus range 1–4 mg/kg.
• Lactate may lag behind MAP: macro stabilization precedes microcellular recovery.
• Limitations: 12-hour window, no long-term survival/infusion data, female-only cohort and potential estrogen “buffer.”

-

Episode timeline

• 0:19–1:36 — The ICU paradox: brute-force stabilization can starve the microsystem
• 1:36–3:24 — Paper setup + why a microdose of methylene blue challenges standard critical care
• 3:24–5:23 — Vasoplegia mechanics: iNOS overexpression, NO flood, sGC/cGMP “relaxation jam”
• 5:23–7:50 — Why vasopressors backfire: “duct tape” constriction → microvascular hypoperfusion → organ ischemia; “de-catecholaminization”
• 7:50–9:51 — Why methylene blue is different: redox agent + blocks NO signaling at sGC and suppresses iNOS
• 9:51–11:26 — Why CLP (cecal ligation & puncture) models real sepsis better than endotoxin injection
• 11:26–12:16 — Dose-mapping design: 10 vs 50 vs 100 mg/kg and the “razor-thin” window
• 12:16–15:42 — 10 mg/kg “Goldilocks” outcomes: MAP recovery, lung protection (PF ratio), kidney function (urea), ↓ IL-1β, redox improvements
• 15:42–17:30 — 100 mg/kg failure: pro-oxidant flip, acid-base collapse, ALT spike, early mortality
• 17:30–19:17 — Translational math: body-surface-area scaling → ~1.6 mg/kg human; aligns with 1–4 mg/kg ICU range
• 19:17–22:27 — Limitations: 12-hour snapshot, lactate lag, infusion questions; why you can’t “chase lactate” instantly
• 22:27–24:35 — Sex-hormone confound: female-only cohort, estrogen’s endothelial/anti-inflammatory buffering; need dual-sex replication
• 24:35–27:39 — Final synthesis: save microvasculature, not just monitor numbers; broader redox implications for chronic inflammation

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram